ghc-20220930
false2022Q3000010488912/311P7Y00001048892022-01-012022-09-300000104889us-gaap:CommonClassAMember2022-10-28xbrli:shares0000104889us-gaap:CommonClassBMember2022-10-280000104889us-gaap:ServiceMember2022-07-012022-09-30iso4217:USD0000104889us-gaap:ServiceMember2021-07-012021-09-300000104889us-gaap:ServiceMember2022-01-012022-09-300000104889us-gaap:ServiceMember2021-01-012021-09-300000104889us-gaap:ProductMember2022-07-012022-09-300000104889us-gaap:ProductMember2021-07-012021-09-300000104889us-gaap:ProductMember2022-01-012022-09-300000104889us-gaap:ProductMember2021-01-012021-09-3000001048892022-07-012022-09-3000001048892021-07-012021-09-3000001048892021-01-012021-09-30iso4217:USDxbrli:shares00001048892022-09-3000001048892021-12-3100001048892020-12-3100001048892021-09-300000104889us-gaap:CommonStockMember2021-12-310000104889us-gaap:AdditionalPaidInCapitalMember2021-12-310000104889us-gaap:RetainedEarningsMember2021-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000104889us-gaap:TreasuryStockMember2021-12-310000104889us-gaap:NoncontrollingInterestMember2021-12-310000104889us-gaap:RetainedEarningsMember2022-01-012022-03-3100001048892022-01-012022-03-310000104889us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000104889us-gaap:TreasuryStockMember2022-01-012022-03-310000104889us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000104889us-gaap:CommonStockMember2022-03-310000104889us-gaap:AdditionalPaidInCapitalMember2022-03-310000104889us-gaap:RetainedEarningsMember2022-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000104889us-gaap:TreasuryStockMember2022-03-310000104889us-gaap:NoncontrollingInterestMember2022-03-3100001048892022-03-310000104889us-gaap:RetainedEarningsMember2022-04-012022-06-3000001048892022-04-012022-06-300000104889us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000104889us-gaap:TreasuryStockMember2022-04-012022-06-300000104889us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000104889us-gaap:CommonStockMember2022-06-300000104889us-gaap:AdditionalPaidInCapitalMember2022-06-300000104889us-gaap:RetainedEarningsMember2022-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000104889us-gaap:TreasuryStockMember2022-06-300000104889us-gaap:NoncontrollingInterestMember2022-06-3000001048892022-06-300000104889us-gaap:RetainedEarningsMember2022-07-012022-09-300000104889us-gaap:NoncontrollingInterestMember2022-07-012022-09-300000104889us-gaap:TreasuryStockMember2022-07-012022-09-300000104889us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000104889us-gaap:CommonStockMember2022-09-300000104889us-gaap:AdditionalPaidInCapitalMember2022-09-300000104889us-gaap:RetainedEarningsMember2022-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000104889us-gaap:TreasuryStockMember2022-09-300000104889us-gaap:NoncontrollingInterestMember2022-09-300000104889us-gaap:CommonStockMember2020-12-310000104889us-gaap:AdditionalPaidInCapitalMember2020-12-310000104889us-gaap:RetainedEarningsMember2020-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000104889us-gaap:TreasuryStockMember2020-12-310000104889us-gaap:NoncontrollingInterestMember2020-12-310000104889us-gaap:RetainedEarningsMember2021-01-012021-03-3100001048892021-01-012021-03-310000104889us-gaap:NoncontrollingInterestMember2021-01-012021-03-310000104889us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000104889us-gaap:TreasuryStockMember2021-01-012021-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000104889us-gaap:CommonStockMember2021-03-310000104889us-gaap:AdditionalPaidInCapitalMember2021-03-310000104889us-gaap:RetainedEarningsMember2021-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000104889us-gaap:TreasuryStockMember2021-03-310000104889us-gaap:NoncontrollingInterestMember2021-03-3100001048892021-03-310000104889us-gaap:RetainedEarningsMember2021-04-012021-06-3000001048892021-04-012021-06-300000104889us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000104889us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300000104889us-gaap:TreasuryStockMember2021-04-012021-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000104889us-gaap:CommonStockMember2021-06-300000104889us-gaap:AdditionalPaidInCapitalMember2021-06-300000104889us-gaap:RetainedEarningsMember2021-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000104889us-gaap:TreasuryStockMember2021-06-300000104889us-gaap:NoncontrollingInterestMember2021-06-3000001048892021-06-300000104889us-gaap:RetainedEarningsMember2021-07-012021-09-300000104889us-gaap:NoncontrollingInterestMember2021-07-012021-09-300000104889us-gaap:TreasuryStockMember2021-07-012021-09-300000104889us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000104889us-gaap:CommonStockMember2021-09-300000104889us-gaap:AdditionalPaidInCapitalMember2021-09-300000104889us-gaap:RetainedEarningsMember2021-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300000104889us-gaap:TreasuryStockMember2021-09-300000104889us-gaap:NoncontrollingInterestMember2021-09-300000104889ghc:TelevisionBroadcastingMember2022-09-30ghc:televisionStationghc:campus0000104889ghc:GrahamHealthcareGroupMember2022-01-012022-09-30ghc:business0000104889ghc:AutomotiveMember2022-01-012022-09-300000104889ghc:GrahamHealthcareGroupMember2022-08-012022-08-310000104889ghc:AppliedBehaviorAnalysisClinicsMemberghc:GrahamHealthcareGroupMember2022-07-31xbrli:pure0000104889ghc:AutodealershipsMemberghc:AutomotiveMember2022-07-05ghc:store0000104889ghc:GrahamHealthcareGroupMember2022-05-012022-05-3100001048892021-01-012021-12-310000104889ghc:EducationMember2021-01-012021-12-310000104889ghc:GrahamHealthcareGroupMember2021-01-012021-12-310000104889ghc:AutomotiveMember2021-01-012021-12-310000104889us-gaap:AllOtherSegmentsMember2021-01-012021-12-310000104889us-gaap:AllOtherSegmentsMemberghc:LeafGroupMember2021-06-142021-06-140000104889us-gaap:AllOtherSegmentsMemberghc:LeafGroupMember2021-06-140000104889ghc:GrahamHealthcareGroupMember2021-12-012021-12-310000104889ghc:GrahamHealthcareGroupMemberghc:WeissMember2021-12-310000104889ghc:GrahamHealthcareGroupMembersrt:MaximumMemberghc:WeissMember2021-12-310000104889ghc:FordAutoDealershipMemberghc:AutomotiveMember2021-12-280000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-09-300000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2021-12-310000104889ghc:ManufacturingMemberghc:HooverTreatedWoodProductsMember2021-03-012021-03-310000104889ghc:ManufacturingMemberghc:HooverTreatedWoodProductsMember2022-09-300000104889ghc:EducationMember2021-11-012021-11-300000104889ghc:MarkelCorporationMember2022-09-300000104889ghc:MarkelCorporationMember2021-12-310000104889ghc:ConcentrationInSingleMarketableEquitySecurityMember2022-09-30ghc:investment0000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:EquitySecuritiesMemberus-gaap:AssetsTotalMember2022-01-012022-09-300000104889ghc:IntersectionMember2022-09-300000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialHomeHealthIllinoisMember2022-09-300000104889ghc:ResidentialHospiceIllinoisMemberghc:GrahamHealthcareGroupMember2022-09-300000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialAndMichiganHospitalJointVentureMember2022-09-300000104889ghc:CelticHealthcareAlleghenyHealthNetworkJointVentureMemberghc:GrahamHealthcareGroupMember2022-09-300000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialHomeHealthIllinoisAndResidentialHospiceIllinoisMember2022-01-012022-03-310000104889ghc:ResidentialHospiceIllinoisMemberghc:GrahamHealthcareGroupMember2022-01-012022-03-310000104889ghc:GrahamHealthcareGroupMember2022-07-012022-09-300000104889ghc:GrahamHealthcareGroupMember2022-01-012022-09-300000104889ghc:GrahamHealthcareGroupMember2021-07-012021-09-300000104889ghc:GrahamHealthcareGroupMember2021-01-012021-09-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2022-09-30iso4217:GBP0000104889ghc:KIHLMemberghc:YorkJointVentureMember2022-01-012022-09-300000104889ghc:SecuredOvernightFinancingRatesSOFRMemberghc:AutomotiveMemberghc:TruistFloorPlanFacilityMember2022-01-012022-09-300000104889ghc:TruistFloorPlanFacilityMemberghc:AutomotiveMember2022-07-050000104889us-gaap:PrimeRateMembersrt:MinimumMemberghc:AutomotiveMemberghc:FordFloorPlanFacilityMember2022-09-300000104889us-gaap:PrimeRateMemberghc:AutomotiveMemberghc:FordFloorPlanFacilityMember2022-01-012022-09-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2022-07-012022-09-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2021-07-012021-09-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2022-01-012022-09-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2021-01-012021-09-300000104889ghc:AutomotiveMember2022-09-300000104889ghc:AutomotiveMember2022-07-012022-09-300000104889ghc:AutomotiveMember2021-07-012021-09-300000104889ghc:AutomotiveMember2021-01-012021-09-300000104889ghc:DekkoMemberghc:ManufacturingMember2021-07-012021-09-300000104889ghc:EducationMember2021-12-310000104889ghc:TelevisionBroadcastingMember2021-12-310000104889ghc:ManufacturingMember2021-12-310000104889ghc:GrahamHealthcareGroupMember2021-12-310000104889ghc:AutomotiveMember2021-12-310000104889us-gaap:AllOtherSegmentsMember2021-12-310000104889ghc:EducationMember2022-01-012022-09-300000104889ghc:TelevisionBroadcastingMember2022-01-012022-09-300000104889ghc:ManufacturingMember2022-01-012022-09-300000104889us-gaap:AllOtherSegmentsMember2022-01-012022-09-300000104889ghc:EducationMember2022-09-300000104889ghc:ManufacturingMember2022-09-300000104889ghc:GrahamHealthcareGroupMember2022-09-300000104889us-gaap:AllOtherSegmentsMember2022-09-300000104889ghc:KaplanInternationalMemberghc:EducationMember2021-12-310000104889ghc:EducationMemberghc:HigherEducationMember2021-12-310000104889ghc:SupplementalEducationMemberghc:EducationMember2021-12-310000104889ghc:KaplanInternationalMemberghc:EducationMember2022-01-012022-09-300000104889ghc:EducationMemberghc:HigherEducationMember2022-01-012022-09-300000104889ghc:SupplementalEducationMemberghc:EducationMember2022-01-012022-09-300000104889ghc:KaplanInternationalMemberghc:EducationMember2022-09-300000104889ghc:EducationMemberghc:HigherEducationMember2022-09-300000104889ghc:SupplementalEducationMemberghc:EducationMember2022-09-300000104889us-gaap:CustomerRelationshipsMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:CustomerRelationshipsMembersrt:MinimumMember2022-01-012022-09-300000104889us-gaap:CustomerRelationshipsMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:CustomerRelationshipsMembersrt:MaximumMember2022-01-012022-09-300000104889us-gaap:CustomerRelationshipsMember2022-09-300000104889us-gaap:CustomerRelationshipsMember2021-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2022-01-012022-09-300000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2022-01-012022-09-300000104889us-gaap:TrademarksAndTradeNamesMember2022-09-300000104889us-gaap:TrademarksAndTradeNamesMember2021-12-310000104889srt:MinimumMemberus-gaap:DatabasesMember2022-01-012022-09-300000104889srt:MinimumMemberus-gaap:DatabasesMember2021-01-012021-12-310000104889us-gaap:DatabasesMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:DatabasesMembersrt:MaximumMember2022-01-012022-09-300000104889us-gaap:DatabasesMember2022-09-300000104889us-gaap:DatabasesMember2021-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2022-01-012022-09-300000104889us-gaap:ContractBasedIntangibleAssetsMember2021-01-012021-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2022-09-300000104889us-gaap:ContractBasedIntangibleAssetsMember2021-12-310000104889us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2022-01-012022-09-300000104889us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2022-01-012022-09-300000104889us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:NoncompeteAgreementsMember2022-09-300000104889us-gaap:NoncompeteAgreementsMember2021-12-310000104889us-gaap:OtherIntangibleAssetsMembersrt:MinimumMember2022-01-012022-09-300000104889us-gaap:OtherIntangibleAssetsMembersrt:MinimumMember2021-01-012021-12-310000104889us-gaap:OtherIntangibleAssetsMembersrt:MaximumMember2021-01-012021-12-310000104889us-gaap:OtherIntangibleAssetsMembersrt:MaximumMember2022-01-012022-09-300000104889us-gaap:OtherIntangibleAssetsMember2022-09-300000104889us-gaap:OtherIntangibleAssetsMember2021-12-310000104889us-gaap:TrademarksAndTradeNamesMember2022-09-300000104889us-gaap:TrademarksAndTradeNamesMember2021-12-310000104889us-gaap:FranchiseRightsMember2022-09-300000104889us-gaap:FranchiseRightsMember2021-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2022-09-300000104889us-gaap:OperatingAndBroadcastRightsMember2021-12-310000104889ghc:LicensureAndAccreditationMember2022-09-300000104889ghc:LicensureAndAccreditationMember2021-12-310000104889us-gaap:OtherIntangibleAssetsMember2022-09-300000104889us-gaap:OtherIntangibleAssetsMember2021-12-310000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2022-09-300000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2021-12-310000104889srt:MinimumMemberghc:FiveYearCreditAgreementMaturingIn2027Member2022-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2027Membersrt:MaximumMember2022-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2022-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2021-12-310000104889ghc:CommercialNoteWithTruistBankMaturingIn20312475MillionMembersrt:MinimumMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn20312475MillionMembersrt:MaximumMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn20312475MillionMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn20312475MillionMember2021-12-310000104889srt:MinimumMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMembersrt:MaximumMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2021-12-310000104889srt:MinimumMemberghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-09-300000104889srt:MaximumMemberghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-09-300000104889ghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2021-12-310000104889ghc:PinnacleBankTermLoanMember2022-09-300000104889ghc:PinnacleBankTermLoanMember2021-12-310000104889srt:MinimumMemberghc:OtherIndebtednessMember2022-09-300000104889ghc:OtherIndebtednessMembersrt:MaximumMember2022-09-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2022-09-300000104889ghc:SecuredOvernightFinancingRatesSOFRMemberghc:USDRevolvingCreditFacilityBorrowingsMember2022-09-302022-09-300000104889us-gaap:PrimeRateMemberghc:USDRevolvingCreditFacilityBorrowingsMember2022-09-302022-09-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2022-09-300000104889ghc:SterlingOvernightInterbankAverageRateSONIAMemberghc:GBPRevolvingCreditFacilityBorrowingsMember2022-09-302022-09-300000104889ghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-07-050000104889ghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-07-052022-07-050000104889ghc:FirstTwentyFourMonthsMemberghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-07-052022-07-050000104889ghc:AutomotiveMemberghc:RemainingNinetySixMonthsMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-07-052022-07-050000104889ghc:SecuredOvernightFinancingRatesSOFRMemberghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032716MillionMember2022-07-052022-07-050000104889ghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-07-050000104889ghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-07-052022-07-050000104889ghc:SecuredOvernightFinancingRatesSOFRMemberghc:AutomotiveMemberghc:CommercialNoteWithTruistBankMaturingIn2032272MillionMember2022-07-052022-07-050000104889us-gaap:InterestRateSwapMemberghc:AutomotiveMember2022-07-050000104889ghc:SecuredOvernightFinancingRatesSOFRMemberghc:AutomotiveMemberus-gaap:InterestRateSwapMember2022-07-050000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2022-07-012022-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2022-01-012022-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2021-07-012021-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2021-01-012021-09-300000104889us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300000104889us-gaap:FairValueMeasurementsRecurringMember2022-09-300000104889us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2021-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2021-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2022-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2020-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2021-09-300000104889country:US2022-07-012022-09-300000104889country:US2022-01-012022-09-300000104889us-gaap:NonUsMember2022-07-012022-09-300000104889us-gaap:NonUsMember2022-01-012022-09-300000104889country:US2021-07-012021-09-300000104889country:US2021-01-012021-09-300000104889us-gaap:NonUsMember2021-07-012021-09-300000104889us-gaap:NonUsMember2021-01-012021-09-300000104889us-gaap:TransferredOverTimeMember2022-07-012022-09-300000104889us-gaap:TransferredOverTimeMember2022-01-012022-09-300000104889us-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300000104889us-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300000104889us-gaap:TransferredOverTimeMember2021-07-012021-09-300000104889us-gaap:TransferredOverTimeMember2021-01-012021-09-300000104889us-gaap:TransferredAtPointInTimeMember2021-07-012021-09-300000104889us-gaap:TransferredAtPointInTimeMember2021-01-012021-09-300000104889ghc:KaplanInternationalMember2022-09-300000104889us-gaap:LongTermContractWithCustomerMember2022-10-01ghc:KaplanInternationalMember2022-09-300000104889ghc:KaplanInternationalMember2021-12-310000104889ghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Memberghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMember2020-04-012020-04-300000104889ghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Memberghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMember2022-07-012022-09-300000104889ghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Memberghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMember2022-01-012022-09-300000104889ghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Memberghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMember2021-07-012021-09-300000104889ghc:GrahamHealthcareGroupMemberghc:CARESActReliefFromCOVID19Memberghc:MedicareAcceleratedAdvancedPaymentProgramReliefFundMember2021-01-012021-09-300000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2022-01-012022-09-300000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2022-10-012022-09-300000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2022-09-300000104889us-gaap:EmployeeStockOptionMember2022-07-012022-09-300000104889us-gaap:EmployeeStockOptionMember2021-07-012021-09-300000104889us-gaap:EmployeeStockOptionMember2022-01-012022-09-300000104889us-gaap:EmployeeStockOptionMember2021-01-012021-09-300000104889us-gaap:RestrictedStockMember2022-07-012022-09-300000104889us-gaap:RestrictedStockMember2021-07-012021-09-300000104889us-gaap:RestrictedStockMember2022-01-012022-09-300000104889us-gaap:RestrictedStockMember2021-01-012021-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-07-012021-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-09-300000104889ghc:DekkoMemberus-gaap:PensionPlansDefinedBenefitMemberghc:SeparationIncentiveProgramMember2021-04-012021-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-01-012022-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-07-012022-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-07-012021-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-01-012021-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2022-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:PrivateEquityFundsMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:EquityFundsUSMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:EquityFundsUSMember2021-12-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2022-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2022-09-300000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2021-12-31ghc:company0000104889ghc:AlphabetAndBerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager1Member2022-01-012022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:InvestmentManager1Memberghc:ForeignInvestmentsMembersrt:MaximumMember2022-09-300000104889ghc:InvestmentManager2Memberghc:BerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300000104889ghc:InvestmentManager2Memberus-gaap:PensionPlansDefinedBenefitMemberghc:ForeignInvestmentsMembersrt:MaximumMember2022-09-300000104889ghc:InvestmentManager2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FixedIncomeSecuritiesMembersrt:MinimumMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2022-01-012022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:DefinedBenefitPlanAssetsTotalMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMember2022-01-012022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:EquitySecuritiesMemberghc:SingleEquityConcentrationMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2022-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberus-gaap:EquitySecuritiesMemberghc:SingleEquityConcentrationMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMember2021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2021-01-012021-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:SingleEquityConcentrationMember2021-12-310000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-07-012021-09-300000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-09-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2022-07-012022-09-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2022-01-012022-09-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2021-07-012021-09-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:HigherEducationMember2021-01-012021-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-07-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-07-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-07-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-07-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-07-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-012021-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-012021-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-01-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-30ghc:claim0000104889srt:MaximumMember2022-09-300000104889srt:MinimumMemberghc:EducationMember2021-05-012021-05-310000104889ghc:EducationMember2021-07-012021-07-310000104889ghc:KaplanSingaporeMemberghc:EducationMember2021-06-012021-06-30ghc:program0000104889ghc:KaplanSingaporeMemberghc:EducationMember2021-08-232021-08-230000104889ghc:KaplanSingaporeMemberghc:EducationMember2021-11-012021-11-300000104889ghc:KaplanSingaporeMemberghc:EducationMember2021-11-300000104889ghc:KaplanSingaporeMemberghc:DiplomasMemberghc:EducationMember2021-11-300000104889ghc:BachelorsMemberghc:KaplanSingaporeMemberghc:EducationMember2021-11-30ghc:segment0000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-01-012021-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-01-012021-09-300000104889us-gaap:CorporateNonSegmentMember2022-07-012022-09-300000104889us-gaap:CorporateNonSegmentMember2021-07-012021-09-300000104889us-gaap:CorporateNonSegmentMember2022-01-012022-09-300000104889us-gaap:CorporateNonSegmentMember2021-01-012021-09-300000104889us-gaap:IntersegmentEliminationMember2022-07-012022-09-300000104889us-gaap:IntersegmentEliminationMember2021-07-012021-09-300000104889us-gaap:IntersegmentEliminationMember2022-01-012022-09-300000104889us-gaap:IntersegmentEliminationMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2022-09-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2022-09-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2022-09-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2021-12-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2022-09-300000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2021-12-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2022-09-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2021-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-12-310000104889us-gaap:CorporateNonSegmentMember2022-09-300000104889us-gaap:CorporateNonSegmentMember2021-12-310000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-07-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-07-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-01-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-01-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2022-07-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2021-07-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2022-01-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2021-01-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2022-07-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2021-07-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2022-01-012022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2021-01-012021-09-300000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-07-012022-09-300000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-07-012021-09-300000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-01-012022-09-300000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-01-012021-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2022-07-012022-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2021-07-012021-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2022-01-012022-09-300000104889us-gaap:OperatingSegmentsMemberus-gaap:IntersubsegmentEliminationsMemberghc:EducationMember2021-01-012021-09-300000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-09-300000104889us-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-12-310000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:EducationMemberghc:HigherEducationMember2021-12-310000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2022-09-300000104889us-gaap:ReportableSubsegmentsMemberus-gaap:OperatingSegmentsMemberghc:SupplementalEducationMemberghc:EducationMember2021-12-310000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2022-09-300000104889ghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMemberghc:EducationMember2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended September 30, 2022
or
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-06714
GRAHAM HOLDINGS COMPANY
(Exact name of registrant as specified in its charter)
Delaware53-0182885
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1300 North 17th Street, Arlington, Virginia

22209
(Address of principal executive offices)(Zip Code)
(703) 345-6300
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $1.00 per share GHCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  .    No  .
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  .    No  .  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated
filer
Non-accelerated
filer
Smaller reporting
company
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  .    No  .  
Shares outstanding at October 28, 2022:
Class A Common Stock – 964,001 Shares
Class B Common Stock – 3,837,643 Shares



GRAHAM HOLDINGS COMPANY
Index to Form 10-Q
 
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
 
 
Condensed Consolidated Statements of Operations
 
 
 
 
Condensed Consolidated Statements of Comprehensive (Loss) Income
 
 
 
 
Condensed Consolidated Balance Sheets
 
 
 
 
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Changes in Common Stockholders' Equity
 
 
 
 
Notes to Condensed Consolidated Financial Statements

Organization, Basis of Presentation and Recent Accounting Pronouncements

Acquisitions and Dispositions of Businesses

Investments

Accounts Receivable, Accounts Payable and Accrued Liabilities

Inventories, Contracts in Progress and Vehicle Floor Plan Payable

Goodwill and Other Intangible Assets

Debt

Fair Value Measurements

Revenue From Contracts With Customers

Earnings Per Share

Pension and Postretirement Plans

Other Non-Operating Income

Accumulated Other Comprehensive Income (Loss)

Contingencies

Business Segments
Item 2.
Management’s Discussion and Analysis of Results of Operations and Financial Condition
 
 
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
 
 
 
Item 4.
Controls and Procedures
 
 
PART II. OTHER INFORMATION
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 6.
Exhibits
 
 
Signatures



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
  
(in thousands, except per share amounts)2022202120222021
Operating Revenues
Sales of services$588,166 $515,280 $1,708,848 $1,509,986 
Sales of goods424,272 294,156 1,151,613 813,057 
1,012,438 809,436 2,860,461 2,323,043 
Operating Costs and Expenses    
Cost of services sold (exclusive of items shown below)342,138 307,138 996,821 906,555 
Cost of goods sold (exclusive of items shown below)352,619 241,539 945,265 647,218 
Selling, general and administrative223,857 215,891 676,563 587,181 
Depreciation of property, plant and equipment19,657 18,741 58,545 51,886 
Amortization of intangible assets14,635 15,981 44,436 43,807 
Impairment of goodwill and other long-lived assets 26,753  31,568 
  952,906 826,043 2,721,630 2,268,215 
Income (Loss) from Operations59,532 (16,607)138,831 54,828 
Equity in (losses) earnings of affiliates, net(1,111)12,964 2,920 28,168 
Interest income803 (79)2,214 2,687 
Interest expense(11,579)(9,343)(38,969)(25,144)
Non-operating pension and postretirement benefit income, net50,687 27,561 152,063 81,564 
(Loss) gain on marketable equity securities, net(54,250)14,069 (172,878)176,981 
Other income, net2,358 5,218 6,410 27,660 
Income Before Income Taxes46,440 33,783 90,591 346,744 
Provision for (Benefit from) Income Taxes12,600 (5,900)26,800 78,500 
Net Income33,840 39,683 63,791 268,244 
Net Income Attributable to Noncontrolling Interests(1,060)(97)(2,872)(850)
Net Income Attributable to Graham Holdings Company Common Stockholders$32,780 $39,586 $60,919 $267,394 
Per Share Information Attributable to Graham Holdings Company Common Stockholders
      
Basic net income per common share$6.78 $7.93 $12.51 $53.49 
Basic average number of common shares outstanding4,808 4,961 4,841 4,966 
Diluted net income per common share$6.76 $7.90 $12.48 $53.33 
Diluted average number of common shares outstanding4,820 4,977 4,853 4,980 
See accompanying Notes to Condensed Consolidated Financial Statements.
1


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (UNAUDITED)
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Net Income$33,840 $39,683 $63,791 $268,244 
Other Comprehensive Loss, Before Tax      
Foreign currency translation adjustments:      
Translation adjustments arising during the period(44,260)(16,033)(86,926)(15,352)
Pension and other postretirement plans:        
Amortization of net prior service cost included in net income
716 793 2,148 2,377 
Amortization of net actuarial gain included in net income
(18,083)(1,066)(53,939)(4,419)
  (17,367)(273)(51,791)(2,042)
Cash flow hedges gains2,202 169 4,935 803 
Other Comprehensive Loss, Before Tax(59,425)(16,137)(133,782)(16,591)
Income tax benefit related to items of other comprehensive loss
3,970 11 12,213 342 
Other Comprehensive Loss, Net of Tax(55,455)(16,126)(121,569)(16,249)
Comprehensive (Loss) Income(21,615)23,557 (57,778)251,995 
Comprehensive income attributable to noncontrolling interests
(1,060)(97)(2,872)(850)
Total Comprehensive (Loss) Income Attributable to Graham Holdings Company$(22,675)$23,460 $(60,650)$251,145 

See accompanying Notes to Condensed Consolidated Financial Statements.
2


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
As of
(in thousands)September 30,
2022
December 31,
2021
  (Unaudited)  
Assets    
Current Assets    
Cash and cash equivalents$149,773 $145,886 
Restricted cash20,436 12,175 
Investments in marketable equity securities and other investments610,756 824,445 
Accounts receivable, net537,561 607,471 
Inventories and contracts in progress209,804 141,471 
Prepaid expenses87,166 81,741 
Income taxes receivable21,934 32,744 
Other current assets1,943 1,241 
Total Current Assets1,639,373 1,847,174 
Property, Plant and Equipment, Net468,173 468,126 
Lease Right-of-Use Assets421,303 437,969 
Investments in Affiliates169,422 155,444 
Goodwill, Net1,631,440 1,649,582 
Indefinite-Lived Intangible Assets174,915 142,180 
Amortized Intangible Assets, Net202,260 247,120 
Prepaid Pension Cost2,392,746 2,306,514 
Deferred Income Taxes6,896 7,900 
Deferred Charges and Other Assets (includes $646 and $782 of restricted cash)
170,603 163,516 
Total Assets$7,277,131 $7,425,525 
Liabilities and Equity    
Current Liabilities    
Accounts payable and accrued liabilities$556,646 $583,629 
Deferred revenue362,351 358,720 
Income taxes payable2,551 4,585 
Current portion of lease liabilities70,100 77,655 
Current portion of long-term debt141,802 141,749 
Dividends declared7,606  
Total Current Liabilities1,141,056 1,166,338 
Accrued Compensation and Related Benefits155,966 175,391 
Other Liabilities33,741 36,497 
Deferred Income Taxes668,964 676,706 
Mandatorily Redeemable Noncontrolling Interest27,142 13,661 
Lease Liabilities387,142 405,200 
Long-Term Debt568,534 525,752 
Total Liabilities2,982,545 2,999,545 
Commitments and Contingencies (Note 14)
Redeemable Noncontrolling Interests17,625 14,311 
Preferred Stock  
Common Stockholders’ Equity    
Common stock20,000 20,000 
Capital in excess of par value394,609 389,456 
Retained earnings7,156,952 7,126,761 
Accumulated other comprehensive income, net of taxes  
Cumulative foreign currency translation adjustment(93,224)(6,298)
Unrealized gain on pensions and other postretirement plans940,714 979,157 
Cash flow hedges2,329 (1,471)
Cost of Class B common stock held in treasury(4,161,672)(4,108,022)
Total Common Stockholders’ Equity4,259,708 4,399,583 
Noncontrolling Interests17,253 12,086 
Total Equity4,276,961 4,411,669 
Total Liabilities and Equity$7,277,131 $7,425,525 
See accompanying Notes to Condensed Consolidated Financial Statements.
3


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
  Nine Months Ended 
 September 30
(in thousands)20222021
Cash Flows from Operating Activities    
Net Income$63,791 $268,244 
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and goodwill and other long-lived asset impairments102,981 127,261 
Amortization of lease right-of-use asset51,344 55,246 
Net pension benefit and special separation benefit expense(136,411)(68,644)
Loss (gain) on marketable equity securities and cost method investments, net172,318 (179,737)
Gain on disposition of businesses, property, plant and equipment and investments, net(2,177)(14,406)
Provision for doubtful trade receivables2,831 4,171 
Stock-based compensation expense, net of forfeitures4,552 4,686 
Foreign exchange loss (gain)1,973 (674)
Equity in earnings of affiliates, net of distributions
5,167 (11,364)
Provision for deferred income taxes9,189 43,580 
Accretion expense and change in fair value of contingent consideration liabilities(3,898)(4,325)
Change in operating assets and liabilities:
Accounts receivable58,940 (27,350)
Inventories(47,486)21,117 
Accounts payable and accrued liabilities(33,994)(7,979)
Deferred revenue36,676 33,561 
Income taxes receivable/payable(7,495)10,724 
Lease liabilities(59,612)(61,775)
Other assets and other liabilities, net(19,698)3,192 
Other4,674 1,743 
Net Cash Provided by Operating Activities203,665 197,271 
Cash Flows from Investing Activities    
Investments in certain businesses, net of cash acquired(130,177)(272,428)
Proceeds from sales of marketable equity securities74,233 38,308 
Purchases of property, plant and equipment(57,097)(140,935)
Purchases of marketable equity securities(35,070)(48,036)
Investments in equity affiliates, cost method and other investments
(30,075)(6,610)
Net proceeds from disposition of businesses, property, plant and equipment, and investments
5,580 8,771 
Other 961 474 
Net Cash Used in Investing Activities(171,645)(420,456)
Cash Flows from Financing Activities    
Issuance of borrowings77,299 22,684 
Common shares repurchased(54,581)(21,840)
Dividends paid(23,122)(22,659)
Net proceeds from (repayments of) vehicle floor plan payable11,688 (15,035)
Net (payments) borrowings under revolving credit facilities(11,000)37,696 
Repayments of borrowings(10,564)(16,878)
Deferred payments of acquisitions(4,731)(30,866)
Proceeds from bank overdrafts4,391 1,137 
Proceeds from exercise of stock options1,531  
Purchase of noncontrolling interest (3,508)
Other905 1,244 
Net Cash Used in Financing Activities(8,184)(48,025)
Effect of Currency Exchange Rate Change(11,824)(2,908)
Net Increase (Decrease) in Cash and Cash Equivalents and Restricted Cash12,012 (274,118)
Beginning Cash and Cash Equivalents and Restricted Cash158,843 423,054 
Ending Cash and Cash Equivalents and Restricted Cash$170,855 $148,936 


See accompanying Notes to Condensed Consolidated Financial Statements.
4


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2021$20,000 $389,456 $7,126,761 $971,388 $(4,108,022)$12,086 $4,411,669 $14,311 
Net income for the period96,566 96,566 
Net income attributable to noncontrolling interests(986)986  
Net loss attributable to redeemable noncontrolling interests
44 44 (44)
Change in redemption value of redeemable noncontrolling interests64 64 64 
Distribution to noncontrolling interest(357)(357)
Dividends on common stock(15,497)(15,497)
Repurchase of Class B common stock(9,527)(9,527)
Issuance of Class B common stock1,437 1,437 
Amortization of unearned stock compensation and stock option expense1,677 1,677 
Other comprehensive loss, net of income taxes(13,135)(13,135)
As of March 31, 2022$20,000 $391,133 $7,206,888 $958,253 $(4,116,112)$12,779 $4,472,941 $14,331 
Net loss for the period(66,615)(66,615)
Noncontrolling interest capital contribution140 140 
Acquisition of noncontrolling interest
512 512 
Net income attributable to noncontrolling interests(929)929  
Acquisition of redeemable noncontrolling interest
 2,164 
Net loss attributable to redeemable noncontrolling interests59 59 (59)
Change in redemption value of redeemable noncontrolling interests64 64 64 
Distribution to noncontrolling interest(872)(872)
Dividends on common stock(7,656)(7,656)
Repurchase of Class B common stock(24,776)(24,776)
Forfeiture of restricted stock awards, net of Class B common stock issuances(462)(415)(877)
Amortization of unearned stock compensation and stock option expense2,302 2,302 
Other comprehensive loss, net of income taxes(52,979)(52,979)
As of June 30, 2022$20,000 $392,973 $7,131,747 $905,274 $(4,141,303)$13,552 $4,322,243 $16,500 
Net income for the period33,840 33,840 
Noncontrolling interest capital contribution2,960 2,960 
Redeemable noncontrolling interest capital contribution 1,050 
Net income attributable to noncontrolling interest(1,049)1,049  
Net income attributable to redeemable noncontrolling interests(11)(11)11 
Change in redemption value of redeemable noncontrolling interests61 61 64 
Distribution to noncontrolling interest(369)(369)
Dividends on common stock(7,575)(7,575)
Repurchase of Class B common stock(20,278)(20,278)
Forfeiture of restricted stock awards, net of Class B common stock issuances(112)(91)(203)
Amortization of unearned stock compensation and stock option expense1,748 1,748 
Other comprehensive loss, net of income taxes(55,455)(55,455)
As of September 30, 2022$20,000 $394,609 $7,156,952 $849,819 $(4,161,672)$17,253 $4,276,961 $17,625 
5


(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2020$20,000 $388,159 $6,804,822 $603,314 $(4,056,993)$7,091 $3,766,393 $11,928 
Net income for the period112,635 112,635 
Net income attributable to noncontrolling interests
(185)185  
Change in redemption value of redeemable noncontrolling interests
697 64 761 (634)
Distribution to noncontrolling interest(126)(126)
Dividends on common stock(15,106)(15,106)
Issuance of Class B common stock, net of restricted stock forfeitures(5,188)5,084 (104)
Amortization of unearned stock compensation and stock option expense
1,589 1,589 
Other comprehensive loss, net of income taxes
(1,203)(1,203)
Purchase of redeemable noncontrolling interest (3,508)
As of March 31, 2021$20,000 $385,257 $6,902,166 $602,111 $(4,051,909)$7,214 $3,864,839 $7,786 
Net income for the period115,926 115,926 
Net income attributable to noncontrolling interests
(699)699  
Net loss attributable to redeemable noncontrolling interests
131 131 (131)
Change in redemption value of redeemable noncontrolling interests
65 65 65 
Distribution to noncontrolling interest(152)(152)
Dividends on common stock(7,553)(7,553)
Forfeiture of restricted stock awards, net of Class B common stock issuances(47)(49)(96)
Amortization of unearned stock compensation and stock option expense
1,672 1,672 
Other comprehensive income, net of income taxes1,080 1,080 
As of June 30, 2021$20,000 $386,882 $7,009,971 $603,191 $(4,051,958)$7,826 $3,975,912 $7,720 
Net income for the period39,683 39,683 
Noncontrolling interest capital contribution1,750 1,750 
Net income attributable to noncontrolling interest(469)469  
Net loss attributable to redeemable noncontrolling interests372 372 (372)
Change in redemption value of redeemable noncontrolling interests64 64 64 
Distribution to noncontrolling interest(206)(206)
Dividends on common stock(7,496)(7,496)
Repurchase of Class B common stock(21,840)(21,840)
Issuance of Class B common stock, net of restricted stock forfeitures(188)121 (67)
Amortization of unearned stock compensation and stock option expense1,692 1,692 
Other comprehensive loss, net of income taxes(16,126)(16,126)
As of September 30, 2021$20,000 $388,386 $7,042,061 $587,065 $(4,073,677)$9,903 $3,973,738 $7,412 

See accompanying Notes to Condensed Consolidated Financial Statements.
6


GRAHAM HOLDINGS COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
Graham Holdings Company (the Company), is a diversified education and media company. The Company’s Kaplan subsidiary provides a wide variety of educational services, both domestically and outside the United States (U.S.). The Company’s media operations comprise the ownership and operation of seven television broadcasting stations, several websites and print publications, podcast content and a marketing solutions provider. The Company’s other business operations include manufacturing, automotive dealerships, consumer internet brands, restaurants and entertainment venues, custom framing services and home health and hospice services.
Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three and nine months ended September 30, 2022 and 2021 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.
2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES
Acquisitions. During 2022, the Company acquired seven businesses: five in healthcare and two in automotive, for $142.8 million in cash and contingent consideration and the assumption of floor plan payables. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.
In August 2022, Graham Healthcare Group (GHG) acquired two small businesses which are included in healthcare.
In July 2022, GHG acquired a 100% interest in a multi-state provider of Applied Behavior Analysis clinics. The acquisition is expected to expand the product offerings of the healthcare division and is included in healthcare.
On July 5, 2022, the Company’s automotive subsidiary acquired two automotive dealerships, including the real property for the dealership operations. In addition to a cash payment and the assumption of $10.9 million in floor plan payables, the automotive subsidiary borrowed $77.4 million to finance the acquisition. The dealerships are operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. These acquisitions expand the Company’s automotive business operations and will be included in automotive.
In May 2022, GHG acquired two small businesses which are included in healthcare.
During 2021, the Company acquired six businesses: two in education, two in healthcare, one in automotive, and one in other businesses for $392.4 million in cash and contingent consideration and the assumption of floor plan payables. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of the acquisition.
On June 14, 2021, the Company acquired all of the outstanding common shares of Leaf Group Ltd. (Leaf) for $308.6 million in cash and the assumption of $9.2 million in liabilities related to their previous stock compensation
7


plan, which will be paid in the future. Leaf is a consumer internet company that builds creator-driven brands in lifestyle and home and art design categories. The acquisition is expected to provide benefits in the future by diversifying the Company’s business operations and providing operating synergies with other business units. The Company includes Leaf in other businesses.
Kaplan acquired certain assets of Projects in Knowledge, a continuing medical education provider for healthcare professionals, and another small business in November 2021. These acquisitions are expected to build upon Kaplan’s existing customer base in the medical and test preparation fields. Both businesses are included in Kaplan’s supplemental education division.
In December 2021, GHG acquired two businesses, a home health business in Florida and a 50.1% interest in Weiss, a physician practice specializing in allergies, asthma and immunology. The minority shareholder of Weiss has an option to put 10% of the shares to the Company annually starting in 2026 and may put all of the shares starting in 2033. The fair value of the redeemable noncontrolling interest in Weiss was $6.6 million at the acquisition date, determined using an income approach. These acquisitions are expected to expand the market the healthcare division serves and are included in healthcare.
On December 28, 2021, the Company’s automotive subsidiary acquired a Ford automotive dealership for cash and the assumption of $16.6 million in floor plan payables (see Note 5). In connection with the acquisition, the automotive subsidiary of the Company borrowed $22.5 million to finance the acquisition. The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. The acquisition expands the Company’s automotive business operations and is included in automotive.
Acquisition-related costs for acquisitions that closed during the first nine months of 2022 and 2021 were $1.6 million in each period and were expensed as incurred. The aggregate purchase price of the 2022 and 2021 acquisitions was allocated as follows (2022 on a preliminary basis), based on acquisition date fair values to the following assets and liabilities:
Purchase Price Allocation
Nine Months EndedYear Ended
(in thousands)September 30, 2022December 31, 2021
Accounts receivable$2,026 $17,878 
Inventory21,278 25,383 
Property, plant and equipment36,254 13,126 
Lease right-of-use assets5,397 25,890 
Goodwill56,902 204,151 
Indefinite-lived intangible assets41,800 22,200 
Amortized intangible assets1,200 99,800 
Other assets474 4,911 
Deferred income taxes241 44,975 
Floor plan payables(10,908)(16,636)
Other liabilities(3,798)(52,567)
Current and noncurrent lease liabilities(6,482)(25,593)
Redeemable noncontrolling interest(2,164)(6,616)
Noncontrolling interest(512) 
Aggregate purchase price, net of cash acquired$141,708 $356,902 
The 2021 fair values include measurement period adjustments related to accounts receivable, goodwill, amortized intangible assets, current and noncurrent lease liabilities, deferred income taxes and contingent consideration. The 2022 fair values recorded were based upon preliminary valuations and the estimates and assumptions used in such valuations are subject to change within the measurement period (up to one year from the acquisition date). The recording of deferred tax assets and liabilities, working capital and the amounts of residual goodwill and other intangibles are not yet finalized. Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $38.0 million and $80.1 million of goodwill for income tax purposes for the acquisitions completed in 2022 and 2021, respectively.
The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The Company’s Condensed Consolidated Statements of Operations for the third quarter of 2022 include aggregate revenues and operating income for the companies acquired in 2022 of $73.2 million and $2.4
8


million, respectively. The Company’s Condensed Consolidated Statements of Operations include aggregate revenues and operating income of $74.7 million and $2.2 million, respectively, for the first nine months of 2022. The following unaudited pro forma financial information presents the Company’s results as if the current year acquisitions had occurred at the beginning of 2021. The unaudited pro forma information also includes the 2021 acquisitions as if they occurred at the beginning of 2020:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Operating revenues$1,012,438 $948,465 $3,026,240 $2,830,653 
Net income34,827 49,563 74,491 283,499 
These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.
Other Transactions. In March 2021, Hoover’s minority shareholders put the remaining outstanding shares to the Company, which had a redemption value of $3.5 million. Following the redemption, the Company owns 100% of Hoover.
3. INVESTMENTS
Money Market Investments. As of September 30, 2022, the Company had money market investments of $5.3 million that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets. The Company had no money market investments as of December 31, 2021.
Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
  As of
September 30,
2022
December 31,
2021
(in thousands)
Total cost
$273,047 $273,201 
Gross unrealized gains
336,830 537,915 
Gross unrealized losses(12,421)(1,119)
Total Fair Value
$597,456 $809,997 
At September 30, 2022 and December 31, 2021, the Company owned 55,430 and 44,430 shares in Markel Corporation (Markel) valued at $60.1 million and $54.8 million, respectively. The Co-Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of September 30, 2022, there was no marketable equity security holding that exceeded 5% of the Company’s total assets.
The Company purchased $35.1 million of marketable equity securities during the first nine months of 2022. The Company purchased $48.0 million of marketable equity securities during the first nine months of 2021.
During the first nine months of 2022, the gross cumulative realized gains from the sales of marketable equity securities were $39.5 million. The total proceeds from such sales were $74.2 million. During the first nine months of 2021, the gross cumulative realized gains from the sales of marketable equity securities were $27.7 million. The total proceeds from such sales were $38.3 million.
The net (loss) gain on marketable equity securities comprised the following:

Three Months Ended 
 September 30

Nine Months Ended 
 September 30
(in thousands)
2022202120222021
(Loss) gain on marketable equity securities, net
$(54,250)$14,069 $(172,878)$176,981 
Less: Net losses (gains) in earnings from marketable equity securities sold and donated
137 411 10,742 (7,750)
Net unrealized (losses) gains in earnings from marketable equity securities still held at the end of the period
$(54,113)

$14,480 

$(162,136)$169,231 
9


Investments in Affiliates. As of September 30, 2022, the Company held an approximate 12% interest in Intersection Holdings, LLC (Intersection), and accounts for its investment under the equity method. The Company holds two of the ten seats of Intersection’s governing board, which allows the Company to exercise significant influence over Intersection. As of September 30, 2022, the Company also held investments in several other affiliates; GHG held a 40% interest in Residential Home Health Illinois, a 40% interest in Residential Hospice Illinois, a 40% interest in the joint venture formed between GHG and a Michigan hospital, and a 40% interest in the joint venture formed between GHG and Allegheny Health Network (AHN). During the first quarter of 2022, GHG invested an additional $18.5 million in the Residential Home Health Illinois and Residential Hospice Illinois affiliates to fund their acquisition of certain home health and hospice assets of the NorthShore University HealthSystem. The transaction diluted GHG’s interest in Residential Hospice Illinois resulting in a $0.6 million gain on the sale of investment in affiliate (see Note 12). For the three and nine months ended September 30, 2022, the Company recorded $3.5 million and $10.5 million, respectively, in revenue for services provided to the affiliates of GHG. For the three and nine months ended September 30, 2021, the Company recorded $2.8 million and $8.0 million, respectively, in revenue for services provided to the affiliates of GHG.
The Company had $54.5 million and $52.5 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of September 30, 2022 and December 31, 2021, respectively.
In the third quarter of 2021, the Company recorded an impairment charge of $6.6 million on one of its investments in affiliates as a result of the challenging economic environment for this business following an announcement by the Chinese government to reform the education sector for private education companies.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which loan is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £20.4 million as of September 30, 2022. The loan is repayable by December 2041.
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $54.9 million and $48.9 million as of September 30, 2022 and December 31, 2021, respectively. During the three and nine months ended September 30, 2022, the Company recorded gains of $0.6 million to those equity securities based on observable transactions. During the first nine months of 2021, the Company recorded gains of $10.5 million to those equity securities based on observable transactions.
4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts receivable consist of the following:
As of
September 30,
2022
December 31,
2021
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $20,930 and $21,836
$509,527 $589,582 
Other receivables28,034 17,889 
 $537,561 $607,471 
Credit loss expense was $0.6 million and $1.7 million for the three months ended September 30, 2022 and 2021, respectively. Credit loss expense was $2.8 million and $4.2 million for the nine months ended September 30, 2022 and 2021, respectively.
Accounts payable and accrued liabilities consist of the following:
As of
September 30,
2022
December 31,
2021
(in thousands)
Accounts payable$118,061 $126,985 
Accrued compensation and related benefits151,865 179,307 
Other accrued liabilities286,720 277,337 
$556,646 $583,629 
Cash overdrafts of $9.9 million and $5.5 million are included in accounts payable as of September 30, 2022 and December 31, 2021, respectively.
10


5. INVENTORIES, CONTRACTS IN PROGRESS AND VEHICLE FLOOR PLAN PAYABLE
Inventories and contracts in progress consist of the following:
As of
September 30,
2022
December 31,
2021
(in thousands)
Raw materials$68,728 $54,944 
Work-in-process14,973 11,506 
Finished goods124,816 72,796 
Contracts in progress1,287 2,225 
 $209,804 $141,471 
The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank (Truist floor plan facility) and Ford Motor Credit Company (Ford floor plan facility). The Truist floor plan facility bears interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) plus 1.19% per annum. On July 5, 2022, the Company entered into an amended agreement with Truist to increase the capacity under the Truist floor plan facility to $80.0 million. The Ford floor plan facility bears interest at variable interest rates that are based on the prime rate, with a floor of 3.5%, plus 1.5% per annum. The weighted average interest rate for the floor plan facilities was 3.5% and 0.9% for the three months ended September 30, 2022 and 2021, respectively. The weighted average interest rate for the floor plan facilities was 2.6% and 1.1% for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, the aggregate capacity under the floor plan facilities was $100.9 million, of which $55.0 million had been utilized, and is included in accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheet. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contains a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of September 30, 2022.
The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended September 30, 2022 and 2021, the Company recognized a reduction in cost of goods sold of $1.4 million and $0.7 million, respectively, related to manufacturer floor plan assistance. For the nine months ended September 30, 2022 and 2021, the Company recognized a reduction in cost of goods sold of $3.4 million and $2.1 million, respectively, related to manufacturer floor plan assistance.
6. GOODWILL AND OTHER INTANGIBLE ASSETS
In the third quarter of 2021, as a result of the emergence of the COVID-19 Delta variant and continued weak product demand in the commercial office electrical products and hospitality sectors caused by the COVID-19 pandemic, the Company performed an interim review of the goodwill and indefinite-lived intangibles of the Dekko reporting unit. As a result of the impairment review, the Company recorded a $26.7 million goodwill impairment charge. The Company estimated the fair value of the reporting unit by utilizing a discounted cash flow model. The carrying value of the reporting unit exceeded the estimated fair value, resulting in a goodwill impairment charge for the amount by which the carrying value exceeded the estimated fair value after taking into account the effect of deferred income taxes. Dekko is included in manufacturing.
Amortization of intangible assets for the three months ended September 30, 2022 and 2021, was $14.6 million and $16.0 million, respectively. Amortization of intangible assets for the nine months ended September 30, 2022 and 2021, was $44.4 million and $43.8 million, respectively. Amortization of intangible assets is estimated to be approximately $15 million for the remainder of 2022, $51 million in 2023, $39 million in 2024, $31 million in 2025, $26 million in 2026 and $40 million thereafter.
11


The changes in the carrying amount of goodwill, by segment, were as follows:
(in thousands)EducationTelevision
Broadcasting
ManufacturingHealthcareAutomotiveOther
Businesses
Total
Balance as of December 31, 2021        
Goodwill$1,186,236 $190,815 $234,993 $118,329 $45,826 $253,399 $2,029,598 
Accumulated impairment losses
(331,151) (34,302)  (14,563)(380,016)
855,085 190,815 200,691 118,329 45,826 238,836 1,649,582 
Measurement period adjustments
1,081   249  (2,183)(853)
Acquisitions   18,031 38,871  56,902 
Foreign currency exchange rate changes
(74,191)     (74,191)
Balance as of September 30, 2022        
Goodwill1,113,126 190,815 234,993 136,609 84,697 251,216 2,011,456 
Accumulated impairment losses
(331,151) (34,302)  (14,563)(380,016)
$781,975 $190,815 $200,691 $136,609 $84,697 $236,653 $1,631,440 
The changes in carrying amount of goodwill at the Company’s education division were as follows:
(in thousands)Kaplan
International
Higher
Education
Supplemental EducationTotal
Balance as of December 31, 2021      
Goodwill$621,268 $174,564 $390,404 $1,186,236 
Accumulated impairment losses (111,324)(219,827)(331,151)
621,268 63,240 170,577 855,085 
Measurement period adjustments  1,081 1,081 
Foreign currency exchange rate changes(74,068) (123)(74,191)
Balance as of September 30, 2022      
Goodwill547,200 174,564 391,362 1,113,126 
Accumulated impairment losses (111,324)(219,827)(331,151)
$547,200 $63,240 $171,535 $781,975 
Other intangible assets consist of the following:
As of September 30, 2022As of December 31, 2021
(in thousands)Useful Life
Range
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
 Carrying
Amount
Amortized Intangible Assets              
Student and customer relationships
210 years
$296,743 $223,485 $73,258 $300,027 $206,714 $93,313 
Trade names and trademarks
215 years
157,303 78,189 79,114 158,365 68,113 90,252 
Databases and technology
36 years
35,848 30,454 5,394 36,585 26,464 10,121 
Network affiliation agreements
10 years
17,400 9,933 7,467 17,400 8,628 8,772 
Noncompete agreements
25 years
1,000 994 6 1,000 991 9 
Other
18 years
69,450 32,429 37,021 68,500 23,847 44,653 
    $577,744 $375,484 $202,260 $581,877 $334,757 $247,120 
Indefinite-Lived Intangible Assets
              
Trade names and trademarks  $77,887     $86,972     
Franchise agreements85,858 44,058 
FCC licenses11,000 11,000 
Licensure and accreditation  150     150     
Other20  
  $174,915 $142,180 
12


7. DEBT
The Company’s borrowings consist of the following:
  As of
(in thousands)MaturitiesStated Interest RateEffective Interest RateSeptember 30,
2022
December 31,
2021
Unsecured notes (1)
20265.75%5.75%$397,367 $396,830 
Revolving credit facility2027
1.61% - 6.63%
2.55%180,662 209,643 
Truist Bank commercial note (2)
2031
1.85% - 4.13%
2.73%23,767 24,504 
Truist Bank commercial note2032
2.10% - 4.56%
3.04%69,542 22,500 
Truist Bank commercial note (3)
2032
3.49% - 4.31%
4.06%26,886  
Pinnacle Bank term loan20244.15%4.19%8,715 9,558 
Other indebtedness2025 - 2030
0.00% - 16.00%
3,397 4,466 
Total Debt710,336 667,501 
Less: current portion(141,802)(141,749)
Total Long-Term Debt$568,534 $525,752 
____________
(1)     The carrying value is net of $2.6 million and $3.2 million of unamortized debt issuance costs as of September 30, 2022 and December 31, 2021, respectively.
(2)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of September 30, 2022 and December 31, 2021.
(3)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of September 30, 2022.
At September 30, 2022 and December 31, 2021, the fair value of the Company’s 5.75% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $389.0 million and $417.5 million, respectively.
On May 3, 2022, the Company amended the revolving credit facility to, among other things, (i) extend the maturity of the facility to May 30, 2027, (ii) eliminate borrowings under separate U.S. Dollar and multicurrency tranches, (iii) update certain interest rate benchmarks including replacing USD London Interbank Offered Rate (LIBOR) with SOFR for borrowings denominated in U.S. dollars, (iv) incorporate a sub-facility for the issuance of letters of credit, and (v) allow for applicable margin for borrowings to be determined and adjusted quarterly based on the Company’s Total Net Leverage Ratio. The outstanding balance on the Company’s $300 million unsecured revolving credit facility was $180.7 million as of September 30, 2022, consisting of U.S. dollar borrowings of $126 million with interest payable at SOFR plus 1.375% or prime rate plus 0.375%, and British Pound (GBP) borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.
On July 5, 2022, the Company’s automotive subsidiary amended its commercial note, dated December 28, 2021, with Truist Bank to, among other things, increase the aggregate loan amount to $71.6 million. The amended commercial note is payable over a 10-year period in monthly installments of $1.0 million, plus accrued and unpaid interest, for the first 24 months and $0.5 million, plus accrued and unpaid interest, for the remaining 96 months due on the first day of each month, with a final payment of the outstanding principal balance due on July 1, 2032. The amended commercial note bears interest at variable rates based on SOFR plus 2.05% per annum. The commercial note contains terms and conditions, including remedies in the event of a default by the automotive subsidiary.
On July 5, 2022, the Company’s automotive subsidiary entered into three additional commercial notes with Truist Bank in an aggregate amount of $27.2 million. The commercial notes are each payable over a 10-year period in aggregate monthly installments of $0.1 million, plus accrued and unpaid interest, due on the first day of each month, with a final payment of the outstanding principal balances due on July 1, 2032. The commercial notes each bear interest at variable rates based on SOFR plus 1.8% per annum. The commercial notes contain terms and conditions, including remedies in the event of a default by the automotive subsidiary. On the same date, the Company’s automotive subsidiary entered into three interest rate swap agreements with a total notional value of $27.2 million and a maturity date of July 1, 2032. The interest rate swap agreements will pay the automotive subsidiary interest on the $27.2 million notional amount based on SOFR plus 1.8% per annum and the automotive subsidiary will pay the counterparty a fixed rate of 4.861% per annum. The new interest rate swap agreements were entered into to convert the variable rate borrowings under these commercial notes into fixed rate borrowings. Based on the terms of the new interest rate swap agreements and the underlying borrowings, the new interest rate swaps were determined to be effective and thus qualify as cash flow hedges.
The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of September 30, 2022 and December 31, 2021. The Company is in compliance with all financial covenants of the revolving credit facility, commercial notes, and Pinnacle Bank term loan as of September 30, 2022.
During the three months ended September 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $714.1 million and $545.9 million, respectively, at average annual interest rates of approximately
13


4.9% and 4.8%, respectively. During the three months ended September 30, 2022 and 2021, the Company incurred net interest expense of $10.8 million and $9.4 million, respectively.
During the nine months ended September 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $676.5 million and $531.3 million, respectively, at average annual interest rates of approximately 4.6% and 4.9%, respectively. During the nine months ended September 30, 2022 and 2021, the Company incurred net interest expense of $36.8 million and $22.5 million, respectively.
During the three and nine months ended September 30, 2022, the Company recorded interest expense of $1.4 million and $12.8 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. During the three and nine months ended September 30, 2021, the Company recorded net interest expense of $2.6 million and $2.7 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment).
14


8. FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of September 30, 2022
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$ $5,306 $ $5,306 
Marketable equity securities (2)
597,456   597,456 
Other current investments (3)
9,294 4,006  13,300 
Interest rate swaps (4) 
 2,781  2,781 
Total Financial Assets
$606,750 $12,093 $ $618,843 
Liabilities
  
  
  
Contingent consideration liabilities (5)
$ $ $9,631 $9,631 
Mandatorily redeemable noncontrolling interest (6)
  27,142 27,142 
Total Financial Liabilities
$ $ $36,773 $36,773 

As of December 31, 2021
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Marketable equity securities (2)
$809,997 $ $ $809,997 
Other current investments (3)
7,230 7,218  14,448 
Total Financial Assets
$817,227 $7,218 $ $824,445 
Liabilities
  
  

  
Contingent consideration liabilities (5)
$ $ $14,881 $14,881 
Interest rate swap (7) 
 2,049  2,049 
Foreign exchange swap (8)
 484  484 
Mandatorily redeemable noncontrolling interest (6)
  13,661 13,661 
Total Financial Liabilities
$ $2,533 $28,542 $31,075 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes U.S. Government Securities, corporate bonds, mutual funds and time deposits. These investments are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments and are classified as either Level 1 or Level 2 in the fair value hierarchy.
(4)
Included in Deferred Charges and Other Assets. The Company utilized a market approach model using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity and market interest rates.
(5)
Included in Accounts payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(6)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(7)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(8)
Included in Accounts payable and accrued liabilities, and valued based on a valuation model that calculates the differential between the contract price and the market-based forward rate.

15


The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2021
$14,881 $13,661 
Acquisition of business397  
Changes in fair value (1)
(5,036)12,799 
Capital contributions
 922 
Accretion of value included in net income (1)
1,139  
Settlements or distributions
(1,750)(240)
As of September 30, 2022
$9,631 $27,142 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2020$37,174 $9,240 
Changes in fair value (1)
(5,482)2,703 
Capital contributions
 50 
Accretion of value included in net income (1)
1,157  
Settlements or distributions
(19,942)(72)
Foreign currency exchange rate changes
(12) 
As of September 30, 2021$12,895 $11,921 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.
During the three and nine months ended September 30, 2021, the Company recorded goodwill and other long-lived asset impairment charges of $26.8 million and $31.6 million, respectively. The remeasurement of goodwill and other long-lived assets is classified as a Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model to determine the estimated fair value of the reporting unit and other long-lived assets. A market value approach was also utilized to supplement the discounted cash flow model. The Company made estimates and assumptions regarding future cash flows, discount rates, market values, and long-term growth rates.
During the three and nine months ended September 30, 2022, the Company recorded gains of $0.6 million to equity securities that are accounted for as cost method investments based on observable transactions for identical or similar investments of the same issuer. During the nine months ended September 30, 2021, the Company recorded gains of $10.5 million to equity securities that are accounted for as cost method investments based on observable transactions for identical or similar investments of the same issuer.
During the third quarter of 2021, the Company recorded an impairment charge of $6.6 million on one of its investments in affiliates (see Note 3).
9. REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company generated 84% and 81% of its revenue from U.S. domestic sales for the three and nine months ended September 30, 2022. The remaining 16% and 19% of revenue was generated from non-U.S. sales for the three and nine months ended September 30, 2022. For the three and nine months ended September 30, 2021, 82% and 79% of revenue was from U.S. domestic sales and the remaining 18% and 21% of revenue was generated from non-U.S. sales.
For the three and nine months ended September 30, 2022, the Company recognized 55% and 58% of its revenue over time as control of the services and goods transferred to the customer, and the remaining 45% and 42% at a point in time, when the customer obtained control of the promised goods. For the three and nine months ended September 30, 2021, the Company recognized 66% and 67% of its revenue over time, and the remaining 34% and 33% at a point in time.
Contract Assets. As of September 30, 2022, the Company recognized a contract asset of $21.0 million related to a contract at a Kaplan International business, which is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $282.1 million related to this contract within the next seven years. As of December 31, 2021, the contract asset was $17.7 million.
16


Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance, including amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:
As of
September 30,
2022
December 31,
2021
%
(in thousands)Change
Deferred revenue$367,048 $363,065 1
In April 2020, GHG received $31.5 million under the expanded Medicare Accelerated and Advanced Payment Program modified by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as a result of COVID-19. The Department of Health and Human Services started to recoup this advance 365 days after the payment was issued. GHG recognized $0.5 million and $12.5 million of the balance in revenue for claims submitted for eligible services for the three and nine months ended September 30, 2022, respectively. The advance has been recouped in full as of September 30, 2022. For the three and nine months ended September 30, 2021, GHG recognized $6.6 million and $11.6 million of the balance in revenue for claims submitted for eligible services.
The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan international division. During the nine months ended September 30, 2022, the Company recognized $296.6 million related to the Company’s deferred revenue balance as of December 31, 2021.
Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of September 30, 2022, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $7.8 million. Kaplan Supplemental Education expects to recognize 66% of this revenue over the next twelve months and the remainder thereafter.
Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:
(in thousands)Balance at
Beginning
of Period
Costs associated with new contractsLess: Costs amortized during the periodOtherBalance
at
End of
Period
2022$26,081 $30,046 $(38,407)$(2,747)$14,973 
The majority of other activity was related to currency translation adjustments for the nine months ended September 30, 2022.
17


10. EARNINGS PER SHARE
The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.
The following reflects the Company’s net income and share data used in the basic and diluted earnings per share computations using the two-class method:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands, except per share amounts)2022202120222021
Numerator:
Numerator for basic earnings per share:        
Net income attributable to Graham Holdings Company common stockholders
$32,780 $39,586 $60,919 $267,394 
Less: Dividends-common stock outstanding and unvested restricted shares
(7,575)(7,496)(30,728)(30,155)
Undistributed earnings25,205 32,090 30,191 237,239 
Percent allocated to common stockholders
99.41 %99.32 %99.41 %99.32 %
25,058 31,872 30,015 235,633 
Add: Dividends-common stock outstanding7,529 7,447 30,549 29,953 
Numerator for basic earnings per share$32,587 $39,319 $60,564 $265,586 
Add: Additional undistributed earnings due to dilutive stock options
1 1  5 
Numerator for diluted earnings per share$32,588 $39,320 $60,564 $265,591 
Denominator:    
Denominator for basic earnings per share:
Weighted average shares outstanding4,808 4,961 4,841 4,966 
Add: Effect of dilutive stock options12 16 12 14 
Denominator for diluted earnings per share4,820 4,977 4,853 4,980 
Graham Holdings Company Common Stockholders:        
Basic earnings per share
$6.78 $7.93 $12.51 $53.49 
Diluted earnings per share
$6.76 $7.90 $12.48 $53.33 
____________
Earnings per share amounts may not recalculate due to rounding.
Diluted earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Weighted average restricted stock17 14 17 11 
The diluted earnings per share amounts for the three and nine months ended September 30, 2022 and September 30, 2021 exclude the effects of 105,000 and 104,000 stock options and contingently issuable shares outstanding, respectively, as their inclusion would have been antidilutive due to a market condition.
In the three and nine months ended September 30, 2022, the Company declared regular dividends totaling $1.58 and $6.32 per common share, respectively. In the three and nine months ended September 30, 2021, the Company declared regular dividends totaling $1.51 and $6.04 per common share, respectively.
18


11. PENSION AND POSTRETIREMENT PLANS
Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Service cost$5,557 $5,775 $16,581 $17,254 
Interest cost7,612 6,754 22,893 20,162 
Expected return on assets(41,779)(34,800)(125,705)(103,078)
Amortization of prior service cost708 711 2,126 2,134 
Recognized actuarial gain(17,538)(1,671)(52,306)(6,234)
Net Periodic Benefit(45,440)(23,231)(136,411)(69,762)
Special separation benefit expense
   1,118 
Total Benefit$(45,440)$(23,231)$(136,411)$(68,644)
In the second quarter of 2021, the Company recorded $1.1 million in expenses related to a Separation Incentive Program for certain Dekko employees, which was funded from the assets of the Company’s pension plan.
The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Service cost$227 $256 $683 $767 
Interest cost823 736 2,467 2,207 
Amortization of prior service cost9 83 27 248 
Recognized actuarial loss166 1,482 499 4,447 
Net Periodic Cost$1,225 $2,557 $3,676 $7,669 
Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds, a U.S. stock index fund, and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:
  As of
  September 30,
2022
December 31,
2021
  
U.S. equities61 %61 %
Private investment funds17 %17 %
U.S. stock index fund8 %9 %
International equities9 %9 %
U.S. fixed income5 %4 %
  100 %100 %
The Company manages approximately 42% of the pension assets internally, of which the majority is invested in private investment funds with the remaining investments in Berkshire Hathaway stock, a U.S. stock index fund, and short-term fixed-income securities. The remaining 58% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in the stock of Alphabet and Berkshire Hathaway, and no more than 30% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway, and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made, and no less than 10% of the assets could be invested in fixed-income securities. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.
In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other
19


indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.
The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of September 30, 2022. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At September 30, 2022, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $783.6 million, or approximately 33% of total plan assets. At December 31, 2021, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $998.8 million, or approximately 29% of total plan assets.
Other Postretirement Plans. The total benefit arising from the Company’s other postretirement plans consists of the following components:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2022202120222021
Interest cost$24 $23 $73 $69 
Amortization of prior service credit(1)(1)(5)(5)
Recognized actuarial gain(711)(877)(2,132)(2,632)
Net Periodic Benefit$(688)$(855)$(2,064)$(2,568)
12. OTHER NON-OPERATING INCOME
A summary of non-operating income is as follows:

Three Months Ended 
 September 30

Nine Months Ended 
 September 30
(in thousands)
2022202120222021
Gain on sale of businesses$1,376 $1,303 $3,074 $2,749 
Foreign currency (loss) gain, net(448)(6)(1,973)674 
Gain on sale of cost method investments8  1,032 6,793 
Gain on sale of investment in affiliate
  604  
Gain on cost method investments
560  560 10,506 
Other gain, net
862 3,921 3,113 6,938 
Total Other Non-Operating Income
$2,358 $5,218 $6,410 $27,660 
The gains on cost method investments result from observable price changes in the fair value of the underlying equity securities accounted for under the cost method (see Notes 3 and 8).
During the three and nine months ended September 30, 2022, the Company recorded contingent consideration gains of $1.4 million and $3.1 million, respectively, related to the disposition of Kaplan University (KU) in 2018. During the three and nine months ended September 30, 2021, the Company recorded contingent consideration gains of $1.3 million and $2.8 million, respectively.
20


13. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The other comprehensive loss consists of the following components:
Three Months Ended September 30
  20222021
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(44,260)$ $(44,260)$(16,033)$ $(16,033)
Pension and other postretirement plans:            
Amortization of net prior service cost included in net income
716 (185)531 793 (188)605 
Amortization of net actuarial gain included in net income
(18,083)4,661 (13,422)(1,066)238 (828)
(17,367)4,476 (12,891)(273)50 (223)
Cash flow hedges:            
Gains for the period2,202 (506)1,696 169 (39)130 
Other Comprehensive Loss$(59,425)$3,970 $(55,455)$(16,137)$11 $(16,126)
  Nine Months Ended September 30
  20222021
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(86,926)$ $(86,926)$(15,352)$ $(15,352)
Pension and other postretirement plans:            
Amortization of net prior service cost included in net income
2,148 (554)1,594 2,377 (615)1,762 
Amortization of net actuarial gain included in net income
(53,939)13,902 (40,037)(4,419)1,143 (3,276)
  (51,791)13,348 (38,443)(2,042)528 (1,514)
Cash flow hedges:          
Gains for the period4,935 (1,135)3,800 803 (186)617 
Other Comprehensive Loss$(133,782)$12,213 $(121,569)$(16,591)$342 $(16,249)
The accumulated balances related to each component of other comprehensive income (loss) are as follows:
(in thousands, net of taxes)Cumulative
Foreign
Currency
Translation
Adjustment
Unrealized Gain
on Pensions
and Other
Postretirement
Plans
Cash Flow
Hedges
Accumulated
Other
Comprehensive
Income
Balance as of December 31, 2021$(6,298)$979,157 $(1,471)$971,388 
Other comprehensive (loss) income before reclassifications
(86,926) 3,342 (83,584)
Net amount reclassified from accumulated other comprehensive income (loss)
 (38,443)458 (37,985)
Other comprehensive (loss) income, net of tax
(86,926)(38,443)3,800 (121,569)
Balance as of September 30, 2022$(93,224)$940,714 $2,329 $849,819 
21


The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
Affected Line Item in the Condensed Consolidated Statements of Operations
  
(in thousands)2022202120222021
Pension and Other Postretirement Plans:        
Amortization of net prior service cost$716 $793 $2,148 $2,377 (1)
Amortization of net actuarial gain(18,083)(1,066)(53,939)(4,419)(1)
  (17,367)(273)(51,791)(2,042)Before tax
  4,476 50 13,348 528 Provision for (Benefit from) Income Taxes
  (12,891)(223)(38,443)(1,514)Net of Tax
Cash Flow Hedges123 149 458 456 Interest expense
Total reclassification for the period$(12,768)$(74)$(37,985)$(1,058)Net of Tax
____________
(1)    These accumulated other comprehensive income components are included in the computation of net periodic pension and postretirement plan cost (see Note 11) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.
14. CONTINGENCIES
Litigation, Legal and Other Matters.  The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $15 million.
In 2015, Kaplan sold substantially all of the assets of the KHE Campuses (KHEC) business to Education Corporation of America. In 2018, certain subsidiaries of Kaplan contributed the institutional assets and operations of KU to a new university: an Indiana nonprofit, public-benefit corporation affiliated with Purdue University, known as Purdue University Global. Kaplan could be held liable to the current owners of KU and the KHEC schools related to the pre-sale conduct of the schools, and the pre-sale conduct of the schools has been and could be the subject of future compliance reviews, regulatory proceedings or lawsuits that could result in monetary liabilities or fines or other sanctions. On May 6, 2021, Kaplan received a notice from the Department of Education (ED) that it would be conducting a fact-finding process pursuant to the borrower defense to repayment (BDTR) regulations to determine the validity of more than 800 BDTR claims and a request for documents related to several of Kaplan’s previously owned schools. Beginning in July 2021, Kaplan started receiving the claims and related information requests. In total, Kaplan received 1,449 borrower defense applications that seek discharge of approximately $35 million in loans (excluding interest). Most claims received are from former KU students. The ED’s process for adjudicating these claims is subject to the borrower defense regulations but it is not clear to what extent the ED will exclude claims based on the underlying statutes of limitations, evidence provided by Kaplan, or any prior investigation related to schools attended by the student applicants.
On June 22, 2022, the ED filed a joint motion for approval of a settlement agreement in Sweet, et al. vs. Cardona, a case pending in the United States District Court for the Northern District of California. Kaplan is not a party to this case. This case was brought in 2019 by a purported class of borrowers demanding that the ED adjudicate all pending borrower defense claims. The settlement proposes that the ED will discharge the loans for students who borrowed to attend any school on a specified list. The list includes approximately 150 schools, including Bauder College, Mount Washington College, Kaplan Career Institute and Kaplan College, as well as Purdue University Global (encompassing the former Kaplan University). This proposed settlement would cover all claims to which Kaplan has previously responded to the ED and may also include new claims for which Kaplan has not received any information or which may still be filed prior to any final approval of the settlement by the court. ED has clarified that while attendance at one of the listed schools justifies presumptive relief for the borrowers, inclusion on the list is not a finding of misconduct by the school and does not provide an evidentiary basis upon which ED could rely to take action against any of the schools. In its July 25, 2022 filing, the ED stated that the proposed settlement in Sweet “creates no independent basis for action against the schools” and “any concrete consequences on the schools – financial or otherwise—could be imposed only after the ED initiates a separate, future proceeding...” The proposed settlement agreement will not be effective unless and until it achieves final court approval. In the event the
22


settlement is approved, the ED will likely be required to separately fully adjudicate the borrowers’ claims under the borrower defense rules process if it wishes to ultimately apply liability to institutions and seek recoupment of discharged amounts.
In any such process Kaplan believes it has defenses that would bar any student discharge or school liability including that the claims are barred by the applicable statute of limitations, unproven, incomplete and fail to meet regulatory filing requirements. Kaplan will vigorously defend any attempt by the ED to hold Kaplan liable for any ultimate student discharges and is responding to all claims with documentary and narrative evidence to refute the allegations, demonstrate their lack of merit, and support the denial of all such claims by the ED. If the ED grants borrower claims through the BTDR process, the ED may seek reimbursement for the amount discharged from Kaplan. If the ED were to initiate a recoupment action against Kaplan, and that action successfully overcame Kaplan’s defenses, Kaplan could be subject to significant liability.
On October 31, 2022, the ED released the final Borrower Defense to Repayment rule with an effective date of July 1, 2023. Compared to the previous rule, this new rule in part, expands actions that can give rise to claims for discharge; provides that the borrower’s claim will be presumed true if the institution does not provide any responsive evidence; provides an easier process for group claims; and relies on current program review penalty hearing processes for discharge recoupment. Under the rule, the recoupment process applies only to loans first disbursed after July 1, 2023; however, the discharge process and standards apply to any pending application regardless of loan date.
On October 27, 2022, the ED released a final rule that among other things, changes the Title IV definition of “Nonprofit” institution to generally exclude from that definition any institution that is an obligor on a debt owed to a former owner of the institution or that maintains a revenue-based service agreement with a former owner of the institution. The final rule has an effective date of July 1, 2023 and could subject Purdue Global to additional regulatory requirements.
In August 2018, Purdue University Global received an updated Provisional Program Participation Agreement (PPPA) from the ED which is necessary for continued participation in the federal Title IV programs after the change in ownership from Kaplan to Purdue. The PPPA expired on June 30, 2021 but was extended to June 30, 2022. In August 2022, Purdue University Global received an extended PPPA that is effective through June 30, 2024. Under the extended PPPA, among other restrictions, Purdue University Global must also report information related to known open investigations and student complaints on a quarterly basis to the ED.
In June 2021, the Committee for Private Education (CPE) in Singapore instructed Kaplan Singapore to cease new enrollments for three marketing diploma programs on both a full and part-time basis due to noncompliance with minimum entry level requirements for admission and to teach out existing students in these programs. On August 23, 2021, the CPE issued the same instructions with respect to the Kaplan Foundation diploma and four information technology diploma programs on both a full and part-time basis. In November 2021, the CPE issued the same instructions with respect to a further 23 full-time or part-time diploma programs. Post regulatory action, Kaplan Singapore was still able to offer 449 programs that remained registered with the CPE, out of which there were 16 diplomas, 361 bachelors and the balance of which were certificate and postgraduate courses. In April 2022, Kaplan Singapore applied for re-registration for certain of the diploma programs and in July 2022 received approval from the CPE. In May 2022, CPE also renewed Kaplan Singapore’s registrations as a private education institution for a four year period expiring in 2026. In October 2022, Kaplan Singapore received approval from the CPE to re-register certain additional full-time and part-time programs. While the regulatory actions by the CPE in 2021 will have a significant adverse impact on Kaplan Singapore’s revenues, operating results and cash flows in the future, the impact is expected to be mitigated as a result of the recently approved registrations of certain impacted programs.
23


15. BUSINESS SEGMENTS
The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, Manufacturing, Healthcare and Automotive.
The following tables summarize the financial information related to each of the Company’s business segments:
  Three months endedNine months ended
September 30September 30
(in thousands)2022202120222021
Operating Revenues    
Education$355,064 $335,999 $1,066,089 $1,005,300 
Television broadcasting135,165 126,498 380,970 360,089 
Manufacturing122,964 99,766 365,966 356,849 
Healthcare87,176 55,445 230,816 160,184 
Automotive211,396 84,702 509,965 242,702 
Other businesses101,207 107,539 308,150 199,477 
Corporate office    
Intersegment elimination(534)(513)(1,495)(1,558)
  $1,012,438 $809,436 $2,860,461 $2,323,043 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Other Long-Lived Assets






Education$22,625 $13,869 $69,952 $57,238 
Television broadcasting53,691 41,911 135,991 113,212 
Manufacturing14,723 (6,942)39,527 27,990 
Healthcare6,953 6,016 21,491 23,312 
Automotive11,050 4,506 25,493 8,815 
Other businesses(17,840)(19,752)(68,301)(57,533)
Corporate office(17,035)(13,481)(40,886)(42,831)
$74,167 $26,127 $183,267 $130,203 
Amortization of Intangible Assets and Impairment of Long-Lived Assets
Education$3,980 $3,955 $12,190 $15,240 
Television broadcasting1,360 1,361 4,080 4,081 
Manufacturing5,076 32,541 15,403 46,138 
Healthcare905 756 2,822 2,317 
Automotive    
Other businesses3,314 4,121 9,941 7,599 
Corporate office    
$14,635 $42,734 $44,436 $75,375 
Income (Loss) from Operations
Education$18,645 $9,914 $57,762 $41,998 
Television broadcasting52,331 40,550 131,911 109,131 
Manufacturing9,647 (39,483)24,124 (18,148)
Healthcare6,048 5,260 18,669 20,995 
Automotive11,050 4,506 25,493 8,815 
Other businesses(21,154)(23,873)(78,242)(65,132)
Corporate office(17,035)(13,481)(40,886)(42,831)
  $59,532 $(16,607)$138,831 $54,828 
Equity in Earnings of Affiliates, Net(1,111)12,964 2,920 28,168 
Interest Expense, Net(10,776)(9,422)(36,755)(22,457)
Non-Operating Pension and Postretirement Benefit Income, Net
50,687 27,561 152,063 81,564 
(Loss) Gain on Marketable Equity Securities, Net
(54,250)14,069 (172,878)176,981 
Other Income, Net
2,358 5,218 6,410 27,660 
Income Before Income Taxes
$46,440 $33,783 $90,591 $346,744 
24


  Three months endedNine months ended
September 30September 30
(in thousands)2022202120222021
Depreciation of Property, Plant and Equipment
Education$8,360 $8,217 $25,396 $23,479 
Television broadcasting2,961 3,462 9,335 10,478 
Manufacturing2,358 2,402 7,109 7,346 
Healthcare590 322 1,455 970 
Automotive1,067 535 2,596 1,555 
Other businesses4,169 3,649 12,198 7,578 
Corporate office152 154 456 480 
  $19,657 $18,741 $58,545 $51,886 
Pension Service Cost  
Education$2,233 $2,339 $6,700 $7,020 
Television broadcasting884 901 2,666 2,692 
Manufacturing276 321 828 962 
Healthcare138 141 417 421 
Automotive6  17  
Other businesses552 458 1,549 1,314 
Corporate office1,468 1,615 4,404 4,845 
  $5,557 $5,775 $16,581 $17,254 
Asset information for the Company’s business segments is as follows:
  As of
(in thousands)September 30, 2022December 31, 2021
Identifiable Assets    
Education$1,847,201 $2,026,782 
Television broadcasting422,465 448,627 
Manufacturing494,335 486,304 
Healthcare245,276 194,823 
Automotive411,440 238,200 
Other businesses620,287 689,872 
Corporate office76,503 68,962 
  $4,117,507 $4,153,570 
Investments in Marketable Equity Securities597,456 809,997 
Investments in Affiliates169,422 155,444 
Prepaid Pension Cost2,392,746 2,306,514 
Total Assets$7,277,131 $7,425,525 
25


The Company’s education division comprises the following operating segments:
  Three Months EndedNine months ended
  September 30September 30
(in thousands)2022202120222021
Operating Revenues      
Kaplan international$193,085 $168,143 $598,469 $521,314 
Higher education80,684 85,518 229,467 239,944 
Supplemental education79,566 80,489 233,416 238,055 
Kaplan corporate and other4,927 3,761 13,726 10,739 
Intersegment elimination(3,198)(1,912)(8,989)(4,752)
  $355,064 $335,999 $1,066,089 $1,005,300 
Income (Loss) From Operations before Amortization of Intangible Assets and Impairment of Long-Lived Assets
Kaplan international$8,503 $(999)$48,130 $23,285 
Higher education9,027 9,525 16,768 18,152 
Supplemental education9,471 11,769 17,671 33,079 
Kaplan corporate and other(4,579)(6,426)(12,783)(17,375)
Intersegment elimination203  166 97 
$22,625 $13,869 $69,952 $57,238 
Amortization of Intangible Assets$3,980 $3,888 $12,190 $11,967 
Impairment of Long-Lived Assets$ $67 $ $3,273 
Income (Loss) from Operations      
Kaplan international$8,503 $(999)$48,130 $23,285 
Higher education9,027 9,525 16,768 18,152 
Supplemental education9,471 11,769 17,671 33,079 
Kaplan corporate and other(8,559)(10,381)(24,973)(32,615)
Intersegment elimination203  166 97 
  $18,645 $9,914 $57,762 $41,998 
Depreciation of Property, Plant and Equipment
        
Kaplan international$5,709 $5,516 $17,258 $15,603 
Higher education988 923 3,072 2,648 
Supplemental education1,570 1,658 4,787 4,904 
Kaplan corporate and other93 120 279 324 
  $8,360 $8,217 $25,396 $23,479 
Pension Service Cost        
Kaplan international$67 $73 $202 $221 
Higher education961 1,109 2,862 3,329 
Supplemental education1,029 954 3,106 2,861 
Kaplan corporate and other176 203 530 609 
  $2,233 $2,339 $6,700 $7,020 
Asset information for the Company’s education division is as follows:
  As of
(in thousands)September 30, 2022December 31, 2021
Identifiable Assets    
Kaplan international$1,336,856 $1,493,868 
Higher education177,042 187,789 
Supplemental education267,826 286,877 
Kaplan corporate and other65,477 58,248 
  $1,847,201 $2,026,782 

26


Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.
This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.
Results of Operations
The Company reported net income attributable to common shares of $32.8 million ($6.76 per share) for the third quarter of 2022, compared to $39.6 million ($7.90 per share) for the third quarter of 2021.
Items included in the Company’s net income for the third quarter of 2022:
$54.2 million in net losses on marketable equity securities (after-tax impact of $40.2 million, or $8.28 per share);
$2.7 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $2.0 million, or $0.42 per share);
a net operating gain of $0.6 million from write-up of a cost method investment (after-tax impact of $0.4 million, or $0.09 per share); and
$1.4 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $1.3 million, or $0.28 per share).
Items included in the Company’s net income for the third quarter of 2021:
a $1.7 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate ($0.34 per share);
$26.8 million in goodwill and other long-lived asset impairment charges (after-tax impact of $22.4 million, or $4.46 per share);
$14.1 million in net gains on marketable equity securities (after-tax impact of $10.3 million, or $2.05 per share);
$16.7 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $12.2 million, or $2.43 per share);
a net non-operating loss of $6.4 million from the write-down of an equity method investment (after-tax impact of $4.8 million, or $0.95 per share);
$2.6 million in net interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest ($0.52 per share); and
a $15.7 million deferred tax benefit arising from a change in the estimated deferred state income tax rate related to the Company’s pension and other postretirement plans ($3.14 per share).
Revenue for the third quarter of 2022 was $1,012.4 million, up 25% from $809.4 million in the third quarter of 2021. Revenues increased at education, television broadcasting, manufacturing, healthcare, and automotive, partially offset by a decline at other businesses. The Company reported operating income of $59.5 million for the third quarter of 2022, compared to an operating loss of $16.6 million for the third quarter of 2021. Operating results improved at all the Company’s divisions.
For the first nine months of 2022, the Company reported net income attributable to common shares of $60.9 million ($12.48 per share), compared to $267.4 million ($53.33 per share) for the first nine months of 2021.
27


Items included in the Company’s net income for the first nine months of 2022:
a $3.2 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate (after-tax impact of $3.1 million, or $0.64 per share);
$172.9 million in net losses on marketable equity securities (after-tax impact of $127.9 million, or $26.19 per share);
$2.8 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $2.1 million, or $0.43 per share);
Non-operating gain of $2.2 million from sales and write-up of cost and equity method investments (after-tax impact of $1.7 million, or $0.34 per share); and
$12.8 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $12.3 million, or $2.51 per share).
Items included in the Company’s net income for the first nine months of 2021:
a $3.9 million net credit related to a fair value change in contingent consideration from a prior acquisition at Corporate ($0.78 per share);
$30.2 million in goodwill and long-lived asset impairment charges (after-tax impact of $24.9 million, or $4.97 per share);
$1.1 million in expenses related to a non-operating Separation Incentive Program (SIP) at manufacturing (after-tax impact of $0.8 million, or $0.16 per share);
$177.0 million in net gains on marketable equity securities (after-tax impact of $128.8 million, or $25.69 per share);
$25.6 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $18.7 million, or $3.72 per share);
a net non-operating gain of $10.8 million from the sale, write-up and write-down of cost and equity method investments (after-tax impact of $7.9 million, or $1.58 per share);
$2.7 million in net interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest ($0.54 per share); and
a $15.7 million deferred tax benefit arising from a change in the estimated deferred state income tax rate related to the Company’s pension and other postretirement plans ($3.14 per share).
Revenue for the first nine months of 2022 was $2,860.5 million, up 23% from $2,323.0 million in the first nine months of 2021. Revenues increased at all the Company’s divisions. The Company reported operating income of $138.8 million for the first nine months of 2022, compared to $54.8 million for the first nine months of 2021. Operating results increased at education, television broadcasting, manufacturing and automotive, offset by declines at healthcare and other businesses.
The COVID-19 pandemic and measures taken to prevent its spread significantly impacted the Company’s results for 2021 and, to a lesser extent, the first nine months of 2022, largely from reduced demand for the Company’s products and services. The Company cannot predict the severity or duration of the pandemic, the extent to which demand for the Company’s products and services will be adversely affected or the degree to which financial and operating results will be negatively impacted.
Division Results
Education  
Education division revenue totaled $355.1 million for the third quarter of 2022, up 6% from $336.0 million for the same period of 2021. Kaplan reported operating income of $18.6 million for the third quarter of 2022, compared to $9.9 million for the third quarter of 2021.
For the first nine months of 2022, education division revenue totaled $1,066.1 million, up 6% from $1,005.3 million for the same period of 2021. Kaplan reported operating income of $57.8 million for the first nine months of 2022, compared to $42.0 million for the first nine months of 2021.
28


The COVID-19 pandemic adversely impacted Kaplan’s operating results during 2021 and, to a lesser extent, the first nine months of 2022. Kaplan serves a large number of students who travel to other countries to study a second language, prepare for licensure, or pursue a higher education degree. Government-imposed travel restrictions and school closures arising from COVID-19 had a negative impact on the ability of certain international students to travel and attend Kaplan’s programs, particularly at Kaplan International’s Language programs (Languages) in 2021.
A summary of Kaplan’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20222021% Change20222021% Change
Revenue            
Kaplan international$193,085 $168,143 15 $598,469 $521,314 15 
Higher education80,684 85,518 (6)229,467 239,944 (4)
Supplemental education79,566 80,489 (1)233,416 238,055 (2)
Kaplan corporate and other4,927 3,761 31 13,726 10,739 28 
Intersegment elimination(3,198)(1,912)— (8,989)(4,752)— 
  $355,064 $335,999 $1,066,089 $1,005,300 
Operating Income (Loss)            
Kaplan international$8,503 $(999)— $48,130 $23,285 — 
Higher education9,027 9,525 (5)16,768 18,152 (8)
Supplemental education9,471 11,769 (20)17,671 33,079 (47)
Kaplan corporate and other(4,579)(6,426)29 (12,783)(17,375)26 
Amortization of intangible assets(3,980)(3,888)(2)(12,190)(11,967)(2)
Impairment of long-lived assets
 (67)—  (3,273)— 
Intersegment elimination203 — — 166 97 — 
  $18,645 $9,914 88 $57,762 $41,998 38 
Kaplan International includes postsecondary education, professional training and language training businesses largely outside the United States. Kaplan International revenue increased 15% for the third quarter and first nine months of 2022 (26% and 23%, respectively, on a constant currency basis). The increase is due largely to growth at Languages, Pathways and UK Professional, partially offset by a decline at Singapore. Kaplan International reported operating income of $8.5 million in the third quarter of 2022, compared to an operating loss of $1.0 million in the third quarter of 2021. Operating income increased to $48.1 million in the first nine months of 2022, compared to $23.3 million in the first nine months of 2021. The improved results are due largely to a reduction in losses at Languages, and improved results at Pathways, partially offset by a decline at Singapore. Overall, Kaplan International’s operating results were negatively impacted by $5 million and $31 million in losses, respectively, incurred at Languages from COVID-19 disruptions for the third quarter and first nine months of 2021. The losses incurred at Languages for the first nine months of 2022 were substantially lower than the prior year, and Languages reported an operating profit in the third quarter of 2022.
Higher Education includes the results of Kaplan as a service provider to higher education institutions. In the third quarter and first nine months of 2022, Higher Education revenue declined 6% and 4%, respectively, due largely to lower costs incurred for reimbursement under the Purdue Global agreement. For the third quarter and first nine months of 2022 and 2021, Kaplan recorded a portion of the fee with Purdue Global based on an assessment of its collectability under the TOSA. Enrollments at Purdue Global for the first nine months of 2022 were approximately the same as the first nine months of 2021. The Company will continue to assess the collectability of the fee with Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to make adjustments to fee amounts recognized in earlier periods. Higher Education results declined in the third quarter and first nine months of 2022 due to increased investment costs incurred related to other university agreements, partially offset by an increase in the Purdue Global fee recorded.
As of September 30, 2022, Kaplan had a total outstanding accounts receivable balance of $88.9 million from Purdue Global related to amounts due for reimbursements for services, fees earned and a deferred fee. Included in this total, Kaplan has a $19.4 million long-term receivable balance due from Purdue Global at September 30, 2022, related to the advance of $20 million during the initial KU Transaction.
Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. In November 2021, Supplemental Education acquired two small businesses. Supplemental Education revenue declined 1% and 2% for the third quarter and first nine months of 2022, respectively, due largely to declines in retail comprehensive test preparation demand, offset in part by growth in demand for professional certifications. Overall, demand for graduate and pre-college test preparation programs has declined due to the strength of U.S. employment markets and the decline in test-takers. Operating results declined in the third quarter and first nine months of 2022 due to lower revenues and increased advertising and product development costs.
29


Kaplan corporate and other represents unallocated expenses of Kaplan, Inc.’s corporate office, other minor businesses and certain shared activities.
Television Broadcasting
A summary of television broadcasting’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20222021% Change20222021% Change
Revenue$135,165 $126,498 $380,970 $360,089 
Operating Income52,331 40,550 29 131,911 109,131 21 
Graham Media Group, Inc. owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media management tools designed to connect newsrooms with their users. Revenue at the television broadcasting division increased 7% to $135.2 million in the third quarter of 2022, from $126.5 million in the same period of 2021. The revenue increase is due primarily to a $19.4 million increase in political advertising revenue, partially offset by a decline in other categories from fewer available advertising spots, and a small decline in retransmission revenues. Operating income for the third quarter of 2022 increased 29% to $52.3 million, from $40.6 million in the same period of 2021, due to increased revenues and a reduction in incentive compensation costs.
Revenue at the television broadcasting division increased 6% to $381.0 million in the first nine months of 2022, from $360.1 million in the same period of 2021. The revenue increase is due to a $24.4 million increase in political revenue, a $2.8 million increase in retransmission revenues, and increases from winter Olympics and Super Bowl advertising revenue at the Company’s NBC affiliates in the first quarter of 2022. Operating income for the first nine months of 2022 increased 21% to $131.9 million, from $109.1 million in the same period of 2021, due to increased revenues and a reduction in incentive compensation costs. While per subscriber rates from cable, satellite and OTT providers have grown, overall subscribers are down due to cord cutting across all platforms, resulting in retransmission revenue net of network fees in 2022 expected to be flat compared with 2021, and this trend is expected to continue in the future.
In May 2022, the Company’s television station in Orlando (WKMG) entered into a new network affiliation agreement with CBS that covers the period July 1, 2022 through June 30, 2026.
Manufacturing
A summary of manufacturing’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20222021% Change20222021% Change
Revenue$122,964 $99,766 23 $365,966 $356,849 
Operating Income (Loss)9,647 (39,483)— 24,124 (18,148)— 
Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce/Dayton, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications.
Manufacturing revenues increased 23% and 3% in the third quarter and first nine months of 2022, respectively. The revenue growth for the third quarter of 2022 is due primarily to significantly increased revenues at Hoover due to higher wood prices and increased product demand. The revenue growth for the first nine months of 2022 is due to increased revenues at Dekko, Joyce and Forney, partially offset by a reduction in revenues at Hoover from lower wood prices in the first half of 2022, but overall modestly higher product demand. Wood prices were highly volatile in 2021 and the first nine months of 2022. Overall, Hoover results included wood gains on inventory sales for both the first nine months of 2022 and 2021; however, wood gains on inventory sales were higher in the first nine months of 2022. For the third quarter of 2022, Hoover results included modest wood losses on inventory sales, compared with significant wood losses on inventory sales in the third quarter of 2021. Manufacturing operating results increased significantly in the third quarter and first nine months of 2022. Operating results increased for the third quarter of 2022 due primarily to a $26.7 million goodwill impairment charge recorded at Dekko during the third quarter of 2021 and significantly improved results at Hoover due to substantial wood losses on inventory sales in the third quarter of 2021. Operating results increased for the first nine months of 2022 due primarily to the Dekko goodwill impairment charge in 2021 and improved results at Hoover and Forney. Excluding the impact of wood gains and losses, Hoover results improved in the third quarter and first nine months of 2022.
30


In the second quarter of 2021, Dekko announced a plan to relocate its manufacturing operations in Shelton, CT to other Dekko manufacturing facilities, which was substantially completed by the end of 2021. In connection with this activity, Dekko implemented a SIP for the affected employees, resulting in $1.1 million in non-operating SIP expense recorded in the second quarter of 2021, which was funded by the assets of the Company’s pension plan.
Healthcare
A summary of healthcare’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20222021% Change20222021% Change
Revenue$87,176 $55,445 57 $230,816 $160,184 44 
Operating Income6,048 5,260 15 18,669 20,995 (11)
Graham Healthcare Group (GHG) provides home health and hospice services in seven states. In December 2021, GHG acquired two small businesses, one of which expanded GHG’s home health operations into Florida. In May 2022, GHG acquired two small businesses, one of which expanded GHG’s home health operations into Kansas and Missouri. In July 2022, GHG acquired a 100% interest in a multi-state provider of Applied Behavior Analysis clinics and in August 2022, GHG acquired two small businesses, which expanded GHG’s hospice services into Missouri and Ohio. GHG provides other healthcare services, including nursing care and prescription services for patients receiving in-home infusion treatments through its 75% interest in CSI Pharmacy Holdings Company, LLC (CSI).
Healthcare revenues increased 57% and 44% for the third quarter and first nine months of 2022, respectively, largely due to significant growth at CSI and from businesses acquired in the fourth quarter of 2021 and the first nine months of 2022, along with growth in home health and hospice services. The increase in GHG operating results in the third quarter of 2022 is due to improved results at CSI, partially offset by net losses from newly acquired businesses and increased marketing, human resources, recruiting and business development costs and overall increased compensation and transportation costs in nursing and clinical staffing. The decline in GHG operating results in the first nine months of 2022 is due to net losses from newly acquired businesses, increased marketing, human resources, recruiting and business development costs and overall increased compensation and transportation costs in nursing and clinical staffing, partially offset by improved results at CSI.
The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Consolidated Statements of Operations. The Company recorded equity in earnings of $1.5 million and $2.5 million for the third quarter of 2022 and 2021, respectively, from these joint ventures. The Company recorded equity in earnings of $5.1 million and $8.0 million for the first nine months of 2022 and 2021, respectively. During the first quarter of 2022, GHG, through its Residential Home Health Illinois and Residential Hospice Illinois affiliates, acquired an interest in the home health and hospice assets of NorthShore University HealthSystem, an integrated healthcare delivery system serving patients throughout the Chicago, IL area. The transaction resulted in a decrease to GHG’s interest in Residential Hospice Illinois and a $0.6 million non-operating gain was recorded in the first quarter of 2022 related to the change in interest.
Automotive
A summary of automotive’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20222021% Change20222021% Change
Revenue$211,396 $84,702 — $509,965 $242,702 — 
Operating Income11,050 4,506 — 25,493 8,815 — 
Automotive includes six automotive dealerships in the Washington, D.C. metropolitan area: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Jeep Bethesda and Ourisman Ford of Manassas, which was acquired on December 28, 2021, from the Battlefield Automotive Group. In addition, on July 5, 2022, the Company acquired a Toyota dealership and a Chrysler-Dodge-Jeep-Ram (CDJR) dealership in Woodbridge, VA from the Lustine Automotive Group. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.
Revenues for the third quarter and first nine months of 2022 increased significantly due to the acquisitions of the Ford, Toyota and CDJR dealerships and sales growth at the Jeep dealership due to an increase in new vehicle inventory provided by the manufacturer and higher average new and used car selling prices at the Jeep, Lexus and Honda dealerships as a result of strong customer demand and new vehicle inventory shortages related to supply
31


chain disruptions and production delays at vehicle manufacturers, partially offset by decreased revenues at the Honda and Lexus dealerships due to volume declines as a result of inventory shortages. Operating results for the third quarter and first nine months of 2022 improved significantly due largely to the Ford, Toyota and CDJR acquisitions and improved results at the Jeep dealership due to increased sales and margins, and at the Lexus dealership due to increased margins, offset by declines at the Honda dealership due to inventory shortages.
Other Businesses
Leaf Group
On June 14, 2021, the Company acquired Leaf Group Ltd. (Leaf), a consumer internet company, headquartered in Santa Monica, CA, that builds enduring, creator-driven brands that reach passionate audiences in large and growing lifestyle categories, including fitness and wellness (Well+Good, Livestrong.com and MyPlate App), and home, art and design (Saatchi Art, Society6 and Hunker). Leaf has three major operating divisions: Society6 Group and Saatchi Art Group (Marketplace businesses) and the Media Group. For the third quarter of 2022, revenue for Society6 Group and the Media Group declined, while Saatchi Art Group reported revenue growth. Overall, Leaf reported significant operating losses for the third quarter and first nine months of 2022.
Clyde’s Restaurant Group
Clyde’s Restaurant Group (CRG) owns and operates ten restaurants and entertainment venues in the Washington, D.C. metropolitan area, including Old Ebbitt Grill and The Hamilton. As a result of the COVID-19 pandemic, CRG temporarily closed its restaurant dining rooms in Maryland and the District of Columbia in December 2020, reopening again for limited indoor dining service in February 2021. Various government-ordered dining restrictions continued until the middle of 2021. CRG’s operating results are seasonal with the second and fourth quarters generally stronger than the first and third quarters. CRG incurred an operating loss for the third quarter of 2022, while reporting a small operating profit for the first nine months of 2022. Both revenues and operating results improved significantly from the third quarter and first nine months of 2021 due largely to the absence of government-ordered dining restrictions in 2022 and a favorable rent concession recorded in the second quarter of 2022. Improvement in both revenue and operating results is expected to continue in the fourth quarter of 2022.
Framebridge
Framebridge is a custom framing service company, headquartered in Washington, D.C., with sixteen retail locations in the Washington, D.C., New York City, Atlanta, GA, Philadelphia, PA, Boston, MA and Chicago, IL areas and two manufacturing facilities in Kentucky and New Jersey. Framebridge opened an additional store in the New York City area in October 2022. Framebridge revenues increased in the third quarter and first nine months of 2022 due to operating additional retail stores compared to the same periods in 2021. Framebridge is an investment stage business and reported significant operating losses in the first nine months of 2022 and 2021.
Code3
Code3 is a performance marketing agency focused on driving performance for brands through three core elements of digital success: media, creative and commerce. Code3 revenue declined in the third quarter and first nine months of 2022 due to sluggish marketing spending by certain advertising clients. Code3 reported operating losses in each of the first nine months of 2022 and 2021. In the second quarter of 2021, Code3 recorded a $1.6 million lease impairment charge (including $0.4 million in property, plant and equipment write-downs).
Other
Other businesses also include Slate and Foreign Policy, which publish online and print magazines and websites; and four investment stage businesses, CyberVista, Decile, Pinna and City Cast. Slate, Foreign Policy, CyberVista, Pinna and City Cast reported revenue increases in the first nine months of 2022. Losses from each of these six businesses in the first nine months of 2022 adversely affected operating results. In October 2022, the Company announced a strategic merger of CyberVista and CyberWire, a B2B cybersecurity audio network to form a new parent company, N2K Networks. N2K Networks will focus on expanding its technology platform to enable development of more resilient enterprise cyber workforces, to pioneer new markets, and to create original “news to knowledge” audio brands. In conjunction with the merger, a Series A funding round led by the Company also closed. The Company’s investment in N2K Networks will be reported as an equity method investment.
Overall, for the third quarter of 2022, operating revenues for other businesses declined due largely to decreased revenues at Leaf and Code3, partially offset by an increase at CRG. For the first nine months of 2022, operating revenues for other businesses increased due largely to the Leaf acquisition and increases at CRG and Framebridge. Operating results declined in the first nine months of 2022 due primarily to increased losses at Leaf and Framebridge, partially offset by improved results at CRG.
32


Corporate Office
Corporate office includes the expenses of the Company’s corporate office and certain continuing obligations related to prior business dispositions.
Equity in Earnings (Losses) of Affiliates
At September 30, 2022, the Company held an approximate 12% interest in Intersection Holdings, LLC (Intersection), a company that provides digital marketing and advertising services and products for cities, transit systems, airports, and other public and private spaces. The Company also holds interests in several other affiliates, including a number of home health and hospice joint ventures managed by GHG and two joint ventures managed by Kaplan. Overall, the Company recorded equity in losses of affiliates of $1.1 million for the third quarter of 2022, compared to earnings of $13.0 million for the third quarter of 2021. These amounts include $2.7 million in net losses for the third quarter of 2022 from affiliates whose operations are not managed by the Company compared to $16.7 million in net earnings for the third quarter of 2021; this includes losses from the Company’s investment in Intersection in the third quarter of 2022. The Company recorded $6.4 million in write-downs in equity in earnings of affiliates related to one of its investments in the third quarter of 2021.
The Company recorded equity in earnings of affiliates of $2.9 million for the first nine months of 2022, compared to $28.2 million for the first nine months of 2021. These amounts include $2.8 million in net losses for the first nine months of 2022 from affiliates whose operations are not managed by the Company compared to $25.6 million in net earnings for the first nine months of 2021; this includes losses from the Company’s investment in Intersection in the first nine months of 2022 and 2021. The Company recorded $6.4 million in write-downs in equity in earnings of affiliates related to one of its investments in the third quarter of 2021.
Net Interest Expense and Related Balances
In connection with the acquisition of the Toyota and CDJR dealerships, in July 2022, the automotive subsidiary of the Company amended its commercial note due January 1, 2032, to increase the aggregate loan amount to $71.6 million. Additionally, the Company borrowed $27.2 million, comprised of three commercial notes, and entered into an interest rate swap to fix the interest rate on the debts at 4.861% per annum.
The Company incurred net interest expense of $10.8 million and $36.8 million for the third quarter and first nine months of 2022, respectively; compared to $9.4 million and $22.5 million for the third quarter and first nine months of 2021, respectively. The Company recorded interest expense of $1.4 million and $12.8 million in the third quarter and first nine months of 2022, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG. The Company recorded net interest expense of $2.6 million in the third quarter of 2021 and $2.7 million in the first nine months of 2021 to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG.
At September 30, 2022, the Company had $710.3 million in borrowings outstanding at an average interest rate of 5.2%, and cash, marketable equity securities and other investments of $781.6 million. At September 30, 2022, the Company had $180.7 million outstanding on its $300 million revolving credit facility.
Non-operating Pension and Postretirement Benefit Income, net
The Company recorded net non-operating pension and postretirement benefit income of $50.7 million and $152.1 million for the third quarter and first nine months of 2022, respectively; compared to $27.6 million and $81.6 million for the third quarter and first nine months of 2021, respectively.
In the second quarter of 2021, the Company recorded $1.1 million in expenses related to a non-operating SIP at manufacturing.
(Loss) Gain on Marketable Equity Securities, net
Overall, the Company recognized $54.3 million and $172.9 million in net losses on marketable equity securities in the third quarter and first nine months of 2022, respectively; compared to $14.1 million and $177.0 million in net gains on marketable equity securities in the third quarter and first nine months of 2021, respectively.
Other Non-Operating Income
The Company recorded total other non-operating income, net, of $2.4 million for the third quarter of 2022, compared to $5.2 million for the third quarter of 2021. The 2022 amounts included $1.4 million in gains related to the sale of businesses and contingent consideration, a $0.6 million fair value increase on a cost method investment, and other items; partially offset by $0.4 million in foreign currency losses. The 2021 amounts included $1.3 million in gains related to the sale of businesses and contingent consideration and other items.
33


The Company recorded total non-operating income, net of $6.4 million for the first nine months of 2022, compared to $27.7 million for the first nine months of 2021. The 2022 amounts included $3.1 million in gains related to the sale of businesses and contingent consideration, $1.0 million in gains on sales of cost method investments, a $0.6 million gain on sale of an equity affiliate, a $0.6 million fair value increase on a cost method investment, and other items; partially offset by $2.0 million in foreign currency losses. The 2021 amounts included $6.8 million in gains on sales of cost method investments, $10.5 million in fair value increases on cost method investments, $2.7 million in gains related to the sale of businesses and contingent consideration, $0.7 million in foreign currency gains, and other items.
Provision for Income Taxes
The Company’s effective tax rate for the first nine months of 2022 and 2021 was 29.6% and 22.6%, respectively. The Company’s effective tax rate for 2021 was favorably impacted by a $15.7 million deferred tax adjustment arising from a change in the estimated deferred state income tax rate attributable to the apportionment formula used in the calculation of deferred taxes related to the Company’s pension and other postretirement plans.
Earnings Per Share
The calculation of diluted earnings per share for the third quarter and first nine months of 2022 was based on 4,819,661 and 4,853,267 weighted average shares outstanding, respectively, compared to 4,976,998 and 4,980,056, respectively, for the third quarter and first nine months of 2021. At September 30, 2022, there were 4,814,182 shares outstanding. On September 10, 2020, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock; the Company has remaining authorization for 176,634 shares as of September 30, 2022.
Financial Condition: Capital Resources and Liquidity
The Company considers the following when assessing its liquidity and capital resources:
 As of
(In thousands)September 30, 2022December 31, 2021
Cash and cash equivalents$149,773 $145,886 
Restricted cash21,082 12,957 
Investments in marketable equity securities and other investments610,756 824,445 
Total debt710,336 667,501 
Cash generated by operations is the Company’s primary source of liquidity. The Company maintains investments in a portfolio of marketable equity securities, which is considered when assessing the Company’s sources of liquidity. An additional source of liquidity includes the undrawn portion of the Company’s $300 million revolving credit facility, amounting to $119.3 million at September 30, 2022.
In March 2020, the U.S. government enacted legislation, including the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) to provide stimulus in the form of financial aid to businesses affected by the COVID-19 pandemic. Under the CARES Act, employers may defer the payment of the employer share of FICA taxes due for the period beginning on March 27, 2020, and ending December 31, 2020. The Company deferred $21.5 million of FICA payments under this program, with $11.1 million of the deferred payments still payable at September 30, 2022. The remaining deferred balance is due by December 31, 2022.
The CARES Act also included provisions to support healthcare providers in the form of grants and changes to Medicare and Medicaid payments. In April 2020, GHG applied for and received $31.5 million under the expanded Medicare Accelerated and Advanced Payment Program, modified by the CARES Act. The Department of Health and Human Services (HHS) started to recoup this advance in April 2021 by withholding a portion of the amount reimbursed for claims submitted for services provided after the beginning of the recoupment period. During the nine months ended September 30, 2022, an amount of $12.5 million was withheld by HHS. The advance has been recouped in full as of September 30, 2022.
During the first nine months of 2022, the Company’s cash and cash equivalents increased by $3.9 million, due to cash generated from operations, the proceeds from the sale of marketable equity securities and net borrowings, which was offset by acquisitions, additional investments in marketable equity securities and equity affiliates, capital expenditures, dividend payments and share repurchases. In the first nine months of 2022, the Company’s borrowings increased by $42.8 million, primarily due to additional borrowings at the Automotive subsidiary, partially offset by repayments under the revolving credit facility.
At September 30, 2022, the Company held approximately $117 million in cash and cash equivalents in businesses domiciled outside the U.S., of which approximately $7 million is not available for immediate use in operations or for
34


distribution. Additionally, Kaplan’s business operations outside the U.S. retain cash balances to support ongoing working capital requirements, capital expenditures, and regulatory requirements. As a result, the Company considers a significant portion of the cash and cash equivalents balance held outside the U.S. as not readily available for use in U.S. operations.
At September 30, 2022, the fair value of the Company’s investments in marketable equity securities was $597.5 million, which includes investments in the common stock of five publicly traded companies. During the first nine months of 2022, the Company purchased $35.1 million of marketable equity securities and sold marketable equity securities that generated proceeds of $74.2 million. At September 30, 2022, the net unrealized gain related to the Company’s investments totaled $324.4 million.
The Company had working capital of $498.3 million and $680.8 million at September 30, 2022 and December 31, 2021, respectively. The Company maintains working capital levels consistent with its underlying business requirements and consistently generates cash from operations in excess of required interest or principal payments.
At September 30, 2022 and December 31, 2021, the Company had borrowings outstanding of $710.3 million and $667.5 million, respectively. The Company’s borrowings at September 30, 2022 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $180.7 million in outstanding borrowings under the Company’s revolving credit facility and commercial notes of $120.2 million at the Automotive subsidiary. The Company’s borrowings at December 31, 2021 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $209.6 million in outstanding borrowings under the Company’s revolving credit facility and commercial notes of $47.0 million at the Automotive subsidiary. The interest on the $400.0 million of 5.75% unsecured notes is payable semiannually on June 1 and December 1.
On May 3, 2022, the Company amended the revolving credit facility agreement to, among other things, extend the maturity date to May 30, 2027.
During the nine months ended September 30, 2022 and 2021, the Company had average borrowings outstanding of approximately $676.5 million and $531.3 million, respectively, at average annual interest rates of approximately 4.6% and 4.9%, respectively. During the nine months ended September 30, 2022 and 2021, the Company incurred net interest expense of $36.8 million and $22.5 million, respectively.
On August 30, 2022, Moody’s affirmed the Company’s credit rating and maintained the outlook as Stable. On April 12, 2022, Standard & Poor’s affirmed the Company’s credit rating and maintained the outlook as Stable.
The Company’s current credit ratings are as follows:
Moody’sStandard & Poor’s
Long-termBa1BB
OutlookStableStable
The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. As of September 30, 2022, the Company had $180.7 million outstanding under the $300 million revolving credit facility. In management’s opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.
In summary, the Company’s cash flows for each period were as follows:
 Nine Months Ended 
 September 30
(In thousands)20222021
Net cash provided by operating activities$203,665 $197,271 
Net cash used in investing activities(171,645)(420,456)
Net cash used in financing activities(8,184)(48,025)
Effect of currency exchange rate change(11,824)(2,908)
Net increase (decrease) in cash and cash equivalents and restricted cash$12,012 $(274,118)
35


Operating Activities. Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. The Company’s net cash flow provided by operating activities were as follows:
 Nine Months Ended 
 September 30
(In thousands)20222021
Net Income$63,791 $268,244 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation, amortization and goodwill and other long-lived asset impairments102,981 127,261 
Amortization of lease right-of-use asset51,344 55,246 
Net pension benefit
(136,411)(68,644)
Other non-cash activities194,629 (156,326)
Change in operating assets and liabilities(72,669)(28,510)
Net Cash Provided by Operating Activities$203,665 $197,271 
Net cash provided by operating activities consists primarily of cash receipts from customers, less disbursements for costs, benefits, income taxes, interest and other expenses.
For the first nine months of 2022 compared to the first nine months of 2021, the increase in net cash provided by operating activities is primarily driven by higher net income, net of non-cash adjustments, and changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily the result of an increase in the collection of cash from customers that were offset by higher purchase of inventories and decreases in accounts payable and accrued liabilities.
Investing Activities. The Company’s net cash flow used in investing activities were as follows:
 Nine Months Ended 
 September 30
(In thousands)20222021
Investments in certain businesses, net of cash acquired$(130,177)$(272,428)
Purchases of property, plant and equipment(57,097)(140,935)
Net proceeds from sales of (purchases of) marketable equity securities39,163 (9,728)
Investments in equity affiliates, cost method and other investments(30,075)(6,610)
Other6,541 9,245 
Net Cash Used in Investing Activities$(171,645)$(420,456)
Acquisitions. During the first nine months of 2022, the Company acquired seven businesses: five in healthcare and two in automotive, for $142.8 million in cash and contingent consideration and the assumption of floor plan payables. GHG acquired two small businesses in August 2022, a 100% interest in a multi-state provider of Applied Behavior Analysis clinics in July 2022, and two small businesses in May 2022. In July 2022, the Company’s automotive subsidiary acquired two automotive dealerships, including the real property for the dealership operations. In addition to a cash payment and the assumption of $10.9 million in floor plan payables, the automotive subsidiary borrowed $77.4 million to finance the acquisition. During the first nine months of 2021, the Company acquired all of the outstanding shares of Leaf for cash and the assumption of $9.2 million in liabilities related to their pre-acquisition stock compensation plan, which will be paid in the future. Leaf is included in other businesses.
Capital Expenditures. The amounts reflected in the Company’s Condensed Consolidated Statements of Cash Flows are based on cash payments made during the relevant periods, whereas the Company’s capital expenditures for the first nine months of 2022 of $56.8 million include assets acquired during the quarter. The Company estimates that its capital expenditures will be in the range of $70 million to $80 million in 2022.
Net proceeds from sale of (purchases of) marketable equity securities. During the first nine months of 2022 and 2021, the Company sold marketable equity securities that generated proceeds of $74.2 million and $38.3 million, respectively. The Company purchased $35.1 million and $48.0 million of marketable equity securities during the first nine months of 2022 and 2021, respectively.
Investment in equity affiliates. During the first nine months of 2022, GHG invested an additional $18.5 million in two affiliates to fund their acquisition of an interest in a health system in Illinois.
36


Financing Activities. The Company’s net cash flow used in financing activities were as follows:
 Nine Months Ended 
 September 30
(In thousands)20222021
Issuance of borrowings$77,299 $22,684 
Net (payments) borrowings under revolving credit facility(11,000)37,696 
Repayments of borrowings(10,564)(16,878)
Net proceeds from (repayments of) vehicle floor plan payable11,688 (15,035)
Common shares repurchased(54,581)(21,840)
Dividends paid(23,122)(22,659)
Other2,096 (31,993)
Net Cash Used in Financing Activities$(8,184)$(48,025)
Borrowings and Vehicle Floor Plan Payable. In July 2022, the Company’s automotive subsidiary amended its commercial note to, among other things, increase the aggregate loan amount to $71.6 million and entered into three commercial notes in an aggregate amount of $27.2 million. The additional borrowings were used to acquire two automotive dealerships, including the real property for the dealership operations. In the first nine months of 2022, the Company made repayments on the $300 million revolving credit facility. In the first nine months of 2022 and 2021, the Company used vehicle floor plan financing to fund the purchase of new, used and service loaner vehicles at its automotive division. The proceeds from (repayments of) the vehicle floor plan payable fluctuates with changes in the amount of vehicle inventory held by the automotive dealerships.
Common Stock Repurchases. During the first nine months of 2022, the Company purchased a total of 93,548 shares of its Class B common stock at a cost of approximately $54.6 million. On September 10, 2020, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock. The Company did not announce a ceiling price or time limit for the purchases. At September 30, 2022, the Company had remaining authorization from the Board of Directors to purchase up to 176,634 shares of Class B common stock.
Dividends. The quarterly dividend rate per share was $1.58 and $1.51 for the first nine months of 2022 and 2021, respectively. The Company expects to pay a dividend of $6.32 per share in 2022.
Other. During the first nine months of 2022, the Company paid $4.7 million related to deferred payments from prior acquisitions. During the first nine months of 2021, the Company paid $30.9 million related to contingent consideration and deferred payments from prior acquisitions, mostly for the 2020 acquisition of Framebridge. During the first nine months of 2022 and 2021, the Company increased the borrowings under its cash overdraft facilities by $4.4 million and $1.1 million, respectively. In March 2021, Hoover’s minority shareholders put their remaining outstanding shares to the Company, which had a redemption value of $3.5 million.
There were no other significant changes to the Company’s contractual obligations or other commercial commitments from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Forward-Looking Statements
All public statements made by the Company and its representatives that are not statements of historical fact, including certain statements in this report, in the Company’s Annual Report on Form 10-K and in the Company’s 2021 Annual Report to Stockholders, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to the duration and severity of the COVID-19 pandemic and its effects on the Company’s operations, financial results, liquidity and cash flows. Other forward-looking statements include comments about expectations related to acquisitions or dispositions or related business activities, including the TOSA, the Company’s business strategies and objectives, anticipated results of license renewal applications, the prospects for growth in the Company’s various business operations and the Company’s future financial performance. As with any projection or forecast, forward-looking statements are subject to various risks and uncertainties, including the risks and uncertainties described in Item 1A of the Company’s Annual Report on Form 10-K, that could cause actual results or events to differ materially from those anticipated in such statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by or on behalf of the Company. The Company assumes no obligation to update any forward-looking statement after the date on which such statement is made, even if new information subsequently becomes available.

37


Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The Company is exposed to market risk in the normal course of its business due primarily to its ownership of marketable equity securities, which are subject to equity price risk; to its borrowing and cash-management activities, which are subject to interest rate risk; and to its foreign business operations, which are subject to foreign exchange rate risk. The Company’s market risk disclosures set forth in its 2021 Annual Report filed on Form 10-K have not otherwise changed significantly.
Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
An evaluation was performed by the Company’s management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal financial officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of September 30, 2022. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures, as designed and implemented, are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
38


PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the quarter ended September 30, 2022, the Company purchased shares of its Class B Common Stock as set forth in the following table:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plan*Maximum Number of Shares that May Yet Be Purchased Under the Plan*
July7,749 $570.48 7,749 204,724 
August9,261 591.16 9,261 195,463 
September18,829 551.38 18,829 176,634 
35,839 $565.79 35,839 
*On September 10, 2020, the Company’s Board of Directors authorized the Company to purchase, on the open market or otherwise, up to 500,000 shares of its Class B Common Stock. There is no expiration date for this authorization. All purchases made during the quarter ended September 30, 2022 were open market transactions and some of these shares were purchased under a 10b5-1 plan.
39


Item 6. Exhibits.
Exhibit Number 
Description 
3.1
 
 
3.2
 
 
3.3
 
 
4.1
 
 
4.2
4.3
31.1
31.2
 
 
32
 
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
*     Furnished herewith.
40


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  GRAHAM HOLDINGS COMPANY
  (Registrant)
   
Date: November 2, 2022 /s/ Timothy J. O’Shaughnessy
  
Timothy J. O’Shaughnessy,
President & Chief Executive Officer
(Principal Executive Officer)
   
Date: November 2, 2022 /s/ Wallace R. Cooney
  Wallace R. Cooney,
Chief Financial Officer
(Principal Financial Officer)
41
Document

Exhibit 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Timothy J. O’Shaughnessy, Chief Executive Officer (principal executive officer) of Graham Holdings Company (the “Registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the Registrant;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 

/s/ Timothy J. O’Shaughnessy
Timothy J. O’Shaughnessy
Chief Executive Officer
November 2, 2022


Document

Exhibit 31.2
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Wallace R. Cooney, Chief Financial Officer (principal financial officer) of Graham Holdings Company (the “Registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the Registrant;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
 
/s/ Wallace R. Cooney
Wallace R. Cooney
Chief Financial Officer
November 2, 2022


Document

Exhibit 32
SECTION 1350 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL
OFFICER
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Graham Holdings Company (the “Company”) on Form 10-Q for the period ended September 30, 2022 (the “Report”), Timothy J. O’Shaughnessy, Chief Executive Officer (principal executive officer) of the Company and Wallace R. Cooney, Chief Financial Officer (principal financial officer) of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Timothy J. O’Shaughnessy
Timothy J. O’Shaughnessy
Chief Executive Officer
November 2, 2022
 
/s/ Wallace R. Cooney
Wallace R. Cooney
Chief Financial Officer
November 2, 2022